Micro Imaging Technology (MMTC) 10-K 13 Feb 14 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Oct. 31, 2013	Feb. 10, 2014
Document And Entity Information	'	'
Entity Registrant Name	'MICRO IMAGING TECHNOLOGY, INC.	'
Entity Central Index Key	'0000808015	'
Document Type	'10-K	'
Document Period End Date	31-Oct-13	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--10-31	'
Entity a Well-known Seasoned Issuer	'No	'
Entity a Voluntary Filer	'No	'
Entity's Current Reporting Status	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Public Float	'	$494,050
Entity Common Stock, Shares Outstanding	'	5,313,027
Document Fiscal Period Focus	'FY	'
Document Fiscal Year Focus	'2013	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Oct. 31, 2013	Oct. 31, 2012
Current assets:	'	'
Cash	$5,007	$90,132
Related party receivables	'	15,269
Inventories	67,487	25,600
Prepaid expenses	897	31,120
Total current assets	73,391	162,121
Fixed assets, net	111,570	123,041
Total assets	184,961	285,162
Current liabilities:	'	'
Notes payable to stockholder, net of unamortized discount of $844 and $5,536 in 2013 and 2012, respectively	200,606	136,464
Convertible notes payable, net of unamortized discount of $60,050 and $3,202 in 2013 and 2012, respectively	89,818	74,166
Accounts payable - trade	336,372	171,578
Accounts payable to officers and directors	131,472	45,583
Accrued payroll	244,031	139,040
Derivative liability	75,557	'
Anti-dilution liability	23,358	65,401
Other accrued expenses	81,016	58,555
Total current liabilities	1,182,230	690,787
Long term liabilities:	'	'
Note payable to stockholder, net of unamortized discount of $0 and $844 in 2013 and 2012, respectively	'	46,106
Redeemable convertible preferred stock, $0.01 par value; 5,200 shares authorized, issued and outstanding at October 31, 2013 and October 31, 2012	26,000	26,000
Total long term liabilities	26,000	72,106
Total liabilities	1,208,230	762,893
Commitments and contingencies	'	'
Stockholders' (deficit):	'	'
Common stock, $0.01 par value; 25,000,000 shares authorized; 5,153,027 and 4,473,715 shares issued and outstanding at October 31, 2013 and October 31, 2012, respectively	51,531	44,737
Additional paid-in capital	45,335,031	44,889,013
Accumulated deficit from previous operating activities	-27,809,201	-27,809,201
Deficit accumulated during the development stage	-18,600,630	-17,602,280
Total stockholders' (deficit)	-1,023,269	-477,731
Total liabilities and stockholders' (deficit)	$184,961	$285,162

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Oct. 31, 2013	Oct. 31, 2012
Statement of Financial Position [Abstract]	'	'
Notes payable, unamortized discount, current	$844	$5,536
Convertible notes payable, unamortized discount, current	60,050	3,202
Notes payable, unamortized discount, noncurrent	$0	$844
Redeemable convertible preferred stock, par value	$0.01	$0.01
Redeemable convertible preferred stock, shares authorized	5,200	5,200
Redeemable convertible preferred stock, shares issued	5,200	5,200
Redeemable convertible preferred stock, shares outstanding	5,200	5,200
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	25,000,000	25,000,000
Common stock, shares issued	5,153,027	4,473,715
Common stock, shares outstanding	5,153,027	4,473,715

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended		96 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2013
Income Statement [Abstract]	'	'	'
Sales	'	'	$58,000
Cost of Sales	'	'	29,886
Gross profit	'	'	28,114
Operating costs and expenses:	'	'	'
Research and development	411,015	489,044	5,842,343
Sales, general and administrative	566,883	716,642	8,477,963
Total operating expenses	977,898	1,205,686	14,320,306
Loss from operations	-977,898	-1,205,686	-14,292,192
Other income (expense):	'	'	'
Interest income	13	92	11,464
Interest expense	-67,045	-384,963	-4,977,635
Gain on derivative instruments	8,753	56,747	158,057
Other income (expense), net	39,427	285,919	512,476
Total other income (expense), net	-18,852	-42,205	-4,295,638
Loss from operations:	'	'	'
Before provision for income tax	-996,750	-1,247,891	-18,587,830
Provision for income tax	-1,600	-1,600	-12,800
Net loss	-998,350	-1,249,491	-18,600,630
Net loss attributable to:	'	'	'
Non-controlling interest	-131,721	-92,409	-1,381,483
Micro Imaging Technology, Inc. stockholders	-866,629	-1,157,082	-17,219,147
Net loss	($998,350)	($1,249,491)	($18,600,630)
Net loss per share, basic and diluted	($0.20)	($0.52)	'
Shares used in computing net loss per share, basic and diluted	4,880,189	2,406,315	'

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders' (Deficit) (USD $)	Series C Convertible Preferred Stock [Member]	Series D Convertible Preferred Stock [Member]	Common Stock [Member]	Class B Common Stock [Member]	Additional Paid-In Capital [Member]	Note Receivable Common Stock [Member]	Accumulated Deficit [Member]	Total
Balance at Oct. 31, 2005	$250,000	$250,000	$259	$2	$25,964,733	($36,247)	($27,809,201)	($1,380,454)
Balance (in shares) at Oct. 31, 2005	250,000	250,000	25,932	168	'	'	'	'
Common stock issued for convertible debt, $70.00 per share	'	'	6	'	43,215	'	'	43,221
Common stock issued for convertible debt, $70.00 per share (in shares)	'	'	617	'	'	'	'	'
Common stock and warrants issued in exchange for surrender of common stock in subsidiary, $170.00 per share	'	'	23	'	253,978	'	'	254,001
Common stock and warrants issued in exchange for surrender of common stock in subsidiary, $170.00 per share (in shares)	'	'	2,353	'	'	'	'	'
Interest expense related to beneficial conversion feature on stock exchanged for subsidiary stock	'	'	'	'	1,944,800	'	'	1,944,800
Common stock issued to officers for services, $40.00 per share	'	'	1	'	3,999	'	'	4,000
Common stock issued to officers for services, $40.00 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to officers for services, $70.00 per share	'	'	1	'	6,999	'	'	7,000
Common stock issued to officers for services, $70.00 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to officers for services, $90.00 per share	'	'	1	'	8,999	'	'	9,000
Common stock issued to officers for services, $90.00 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to officers for services, $100.00 per share	'	'	1	'	9,999	'	'	10,000
Common stock issued to officers for services, $100.00 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to officers for services, $115.00 per share	'	'	1	'	11,499	'	'	11,500
Common stock issued to officers for services, $115.00 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to officers for services, $125.00 per share	'	'	1	'	12,499	'	'	12,500
Common stock issued to officers for services, $125.00 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to officers for services, $130.00 per share	'	'	1	'	12,999	'	'	13,000
Common stock issued to officers for services, $130.00 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to officers for services, $140.00 per share	'	'	1	'	13,999	'	'	14,000
Common stock issued to officers for services, $140.00 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to officers for services, $170.00 per share	'	'	1	'	25,499	'	'	25,500
Common stock issued to officers for services, $170.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $225.00 per share	'	'	2	'	33,748	'	'	33,750
Common stock issued to officers for services, $225.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $250.00 per share	'	'	2	'	37,498	'	'	37,500
Common stock issued to officers for services, $250.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $255.00 per share	'	'	1	'	25,499	'	'	25,500
Common stock issued to officers for services, $255.00 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to directors for services, $170.00 per share	'	'	4	'	67,996	'	'	68,000
Common stock issued to directors for services, $170.00 per share (in shares)	'	'	400	'	'	'	'	'
Common stock issued for services, $70.00 per share	'	'	4	'	27,996	'	'	28,000
Common stock issued for services, $70.00 per share (in shares)	'	'	400	'	'	'	'	'
Common stock issued for services, $170.00 per share	'	'	4	'	67,996	'	'	68,000
Common stock issued for services, $170.00 per share (in shares)	'	'	400	'	'	'	'	'
Common stock issued as commission, $250.00 per share	'	'	1	'	2,999	'	'	3,000
Common stock issued as commission, $250.00 per share (in shares)	'	'	12	'	'	'	'	'
Interest recognized on notes receivable for common stock	'	'	'	'	'	-1,373	'	-1,373
Options and warrants granted to employees and consultants for services	'	'	'	'	45,875	'	'	45,875
Net loss	'	'	'	'	'	'	-3,798,713	-3,798,713
Balance at Oct. 31, 2006	250,000	250,000	315	2	28,622,824	-37,620	-31,607,914	-2,522,393
Balance (in shares) at Oct. 31, 2006	250,000	250,000	31,464	168	'	'	'	'
Common stock issued to officers for services, $50.00 per share	'	'	2	'	7,498	'	'	7,500
Common stock issued to officers for services, $50.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $80.00 per share	'	'	2	'	11,998	'	'	12,000
Common stock issued to officers for services, $80.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $120.00 per share	'	'	3	'	35,997	'	'	36,000
Common stock issued to officers for services, $120.00 per share (in shares)	'	'	300	'	'	'	'	'
Common stock issued to officers for services, $125.00 per share	'	'	4	'	56,246	'	'	56,250
Common stock issued to officers for services, $125.00 per share (in shares)	'	'	450	'	'	'	'	'
Common stock issued to officers for services, $150.00 per share	'	'	2	'	22,498	'	'	22,500
Common stock issued to officers for services, $150.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $160.00 per share	'	'	2	'	23,998	'	'	24,000
Common stock issued to officers for services, $160.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $175.00 per share	'	'	2	'	26,248	'	'	26,250
Common stock issued to officers for services, $175.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $200.00 per share	'	'	3	'	59,997	'	'	60,000
Common stock issued to officers for services, $200.00 per share (in shares)	'	'	300	'	'	'	'	'
Common stock issued to officers and directors for consulting services, $185.00 per share	'	'	40	'	739,960	'	'	740,000
Common stock issued to officers and directors for consulting services, $185.00 per share (in shares)	'	'	4,000	'	'	'	'	'
Common stock issued in private placement offering, $60.00 per share	'	'	42	'	239,569	'	'	239,611
Common stock issued in private placement offering, $60.00 per share (in shares)	'	'	4,228	'	'	'	'	'
Common stock issued in private placement offering, $250.00 per share	'	'	55	'	1,329,945	'	'	1,330,000
Common stock issued in private placement offering, $250.00 per share (in shares)	'	'	5,520	'	'	'	'	'
Common stock issued as commission, $60.00 per share	'	'	1	'	3,682	'	'	3,683
Common stock issued as commission, $60.00 per share (in shares)	'	'	61	'	'	'	'	'
Common stock issued for debt, $100.00 per share	'	'	4	'	42,219	37,620	'	79,843
Common stock issued for debt, $100.00 per share (in shares)	'	'	422	'	'	'	'	'
Common stock issued for convertible debt, $125.00 per share	'	'	126	'	1,574,718	'	'	1,574,844
Common stock issued for convertible debt, $125.00 per share (in shares)	'	'	12,599	'	'	'	'	'
Common stock issued to former licensee for debt, $40.00 per share	'	'	10	'	41,309	'	'	41,319
Common stock issued to former licensee for debt, $40.00 per share (in shares)	'	'	1,033	'	'	'	'	'
Common stock issued upon conversion of Series C Preferred stock	-250,000	'	20	'	249,980	'	'	'
Common stock issued upon conversion of Series C Preferred stock (in shares)	-250,000	'	2,000	'	'	'	'	'
Common stock issued upon conversion of Series D Preferred stock	'	-250,000	10	'	249,990	'	'	'
Common stock issued upon conversion of Series D Preferred stock (in shares)	'	-250,000	100	'	'	'	'	'
Common stock issued or surrendered for uncollectible debt, $150.00 per share	'	'	1	'	20,477	'	'	20,478
Common stock issued or surrendered for uncollectible debt, $150.00 per share (in shares)	'	'	137	'	'	'	'	'
Common stock of subsidiary issued to employees and consultants, $0.001 per share	'	'	'	'	2,665	'	'	2,665
Options and warrants granted to employees and consultants for services	'	'	'	'	93,035	'	'	93,035
Net loss	'	'	'	'	'	'	-2,040,137	-2,040,137
Balance at Oct. 31, 2007	'	'	646	'	33,454,853	'	-33,648,051	-192,552
Balance (in shares) at Oct. 31, 2007	'	'	64,432	'	'	'	'	'
Common stock issued to officers for services, $175.00 per share	'	'	2	'	26,248	'	'	26,250
Common stock issued to officers for services, $175.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $150.00 per share	'	'	2	'	22,498	'	'	22,500
Common stock issued to officers for services, $150.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $135.00 per share	'	'	2	'	20,248	'	'	20,250
Common stock issued to officers for services, $135.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $125.00 per share	'	'	5	'	56,245	'	'	56,250
Common stock issued to officers for services, $125.00 per share (in shares)	'	'	450	'	'	'	'	'
Common stock issued to officers for services, $115.00 per share	'	'	2	'	17,248	'	'	17,250
Common stock issued to officers for services, $115.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $100.00 per share	'	'	2	'	14,998	'	'	15,000
Common stock issued to officers for services, $100.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $90.00 per share	'	'	1	'	13,499	'	'	13,500
Common stock issued to officers for services, $90.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $75.00 per share	'	'	1	'	11,249	'	'	11,250
Common stock issued to officers for services, $75.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $70.00 per share	'	'	1	'	10,499	'	'	10,500
Common stock issued to officers for services, $70.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers for services, $17.50 per share	'	'	1	'	2,624	'	'	2,625
Common stock issued to officers for services, $17.50 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants for debt, $150.00 per share	'	'	11	'	175,331	'	'	175,342
Common stock issued to officers, directors and consultants for debt, $150.00 per share (in shares)	'	'	1,169	'	'	'	'	'
Common stock issued to consultants for services, $140.00 per share	'	'	20	'	279,980	'	'	280,000
Common stock issued to consultants for services, $140.00 per share (in shares)	'	'	2,000	'	'	'	'	'
Common stock issued to consultants for services, $125.00 per share	'	'	5	'	68,745	'	'	68,750
Common stock issued to consultants for services, $125.00 per share (in shares)	'	'	550	'	'	'	'	'
Common stock issued to consultants for services, $40.00 per share	'	'	5	'	19,995	'	'	20,000
Common stock issued to consultants for services, $40.00 per share (in shares)	'	'	500	'	'	'	'	'
Common stock issued to officers and directors for consulting services, $135.00 per share	'	'	20	'	269,980	'	'	270,000
Common stock issued to officers and directors for consulting services, $135.00 per share (in shares)	'	'	2,000	'	'	'	'	'
Common stock issued to officers and directors for consulting services, $25.00 per share	'	'	40	'	99,960	'	'	100,000
Common stock issued to officers and directors for consulting services, $25.00 per share (in shares)	'	'	4,000	'	'	'	'	'
Common stock issued in private placement offering, $83.50 per share	'	'	7	'	59,993	'	'	60,000
Common stock issued in private placement offering, $83.50per share (in shares)	'	'	720	'	'	'	'	'
Common stock issued in private placement offering, $60.00per share	'	'	22	'	131,978	'	'	132,000
Common stock issued in private placement offering, $60.00 per share (in shares)	'	'	2,200	'	'	'	'	'
Common stock issued as commission, $200.00per share	'	'	12	'	239,988	'	'	240,000
Common stock issued as commission, $200.00 per share (in shares)	'	'	1,200	'	'	'	'	'
Common stock issued upon exercise of warrants, $30.00 per share	'	'	4	'	11,996	'	'	12,000
Common stock issued upon exercise of warrants, $30.00 per share (in shares)	'	'	400	'	'	'	'	'
Common stock of subsidiary issued to employees and consultants, $0.001 per share	'	'	'	'	150	'	'	150
Options and warrants granted to employees and consultants for services	'	'	'	'	323,860	'	'	323,860
Interest recognized on beneficial conversion feature of convertible debentures issued	'	'	'	'	153,333	'	'	153,333
Net loss	'	'	'	'	'	'	-2,461,976	-2,461,976
Balance at Oct. 31, 2008	'	'	811	'	35,485,498	'	-36,110,027	-623,718
Balance (in shares) at Oct. 31, 2008	'	'	80,971	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $6.00 per share	'	'	2	'	898	'	'	900
Common stock issued to officers, directors and consultants for services, $6.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $7.69 per share	'	'	240	'	184,260	'	'	184,500
Common stock issued to officers, directors and consultants for services, $7.69 per share (in shares)	'	'	24,000	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $7.75 per share	'	'	2	'	1,159	'	'	1,161
Common stock issued to officers, directors and consultants for services, $7.75 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services, $8.83 per share	'	'	2	'	1,322	'	'	1,324
Common stock issued to officers, directors and consultants for services, $8.83 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services, $9.31 per share	'	'	2	'	1,395	'	'	1,397
Common stock issued to officers, directors and consultants, for services, $9.31 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services, $20.00 per share	'	'	2	'	2,998	'	'	3,000
Common stock issued to officers, directors and consultants, for services, $20.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services, $26.84 per share	'	'	2	'	4,023	'	'	4,025
Common stock issued to officers, directors and consultants, for services, $26.84 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services, $28.09 per share	'	'	10	'	28,078	'	'	28,088
Common stock issued to officers, directors and consultants, for services, $28.09 per share (in shares)	'	'	1,000	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services, $31.25 per share	'	'	2	'	4,686	'	'	4,688
Common stock issued to officers, directors and consultants, for services, $31.25 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services, $35.00 per share	'	'	21	'	74,979	'	'	75,000
Common stock issued to officers, directors and consultants, for services, $35.00 per share (in shares)	'	'	2,143	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services, $44.00 per share	'	'	2	'	6,598	'	'	6,600
Common stock issued to officers, directors and consultants, for services, $44.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $45.00 per share	'	'	2	'	6,748	'	'	6,750
Common stock issued to officers, directors and consultants for services, $45.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $55.00 per share	'	'	2	'	8,248	'	'	8,250
Common stock issued to officers, directors and consultants for services, $55.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $58.25 per share	'	'	40	'	232,960	'	'	233,000
Common stock issued to officers, directors and consultants for services, $58.25 per share (in shares)	'	'	4,000	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $70.25 per share	'	'	1	'	10,537	'	'	10,538
Common stock issued to officers, directors and consultants for services, $70.25 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $76.00 per share	'	'	1	'	11,399	'	'	11,400
Common stock issued to officers, directors and consultants for services, $76.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $77.25 per share	'	'	122	'	942,328	'	'	942,450
Common stock issued to officers, directors and consultants for services, $77.25 per share (in shares)	'	'	12,200	'	'	'	'	'
Common stock issued in private placement offering, $25.00 per share	'	'	40	'	99,960	'	'	100,000
Common stock issued in private placement offering, $25.00 per share (in shares)	'	'	4,000	'	'	'	'	'
Common stock issued to officers, directors and consultants for debt, $50.00 per share	'	'	25	'	128,971	'	'	128,996
Common stock issued to officers, directors and consultants for debt, $50.00 per share (in shares)	'	'	2,500	'	'	'	'	'
Common stock issued to officers, directors and consultants for debt, $26.46 share	'	'	3	'	9,259	'	'	9,262
Common stock issued to officers, directors and consultants for debt, $26.46 share (in shares)	'	'	350	'	'	'	'	'
Common stock issued to officers, directors and consultants for debt, $7.69 per share	'	'	33	'	25,769	'	'	25,802
Common stock issued to officers, directors and consultants for debt, $7.69 per share (in shares)	'	'	3,356	'	'	'	'	'
Common stock issued for convertible debt, $4.50 per share	'	'	77	'	34,923	'	'	35,000
Common stock issued for convertible debt, $4.50 per share (in shares)	'	'	7,778	'	'	'	'	'
Common stock issued for convertible debt, $4.50 per share	'	'	631	'	302,739	'	'	303,370
Common stock issued for convertible debt, $4.50 per share (in shares)	'	'	63,185	'	'	'	'	'
Common stock issued for convertible debt, $6.41 per share	'	'	23	'	14,977	'	'	15,000
Common stock issued for convertible debt, $6.41 per share (in shares)	'	'	2,339	'	'	'	'	'
Common stock issued for convertible debt, $22.77 per share	'	'	175	'	399,825	'	'	400,000
Common stock issued for convertible debt, $22.77 per share (in shares)	'	'	17,567	'	'	'	'	'
Common stock issued in settlement of lawsuit, $37.40 per share	'	'	118	'	443,627	'	'	443,745
Common stock issued in settlement of lawsuit, $37.40 per share (in shares)	'	'	11,800	'	'	'	'	'
Options and warrants granted to employees and consultants for services	'	'	'	'	101,234	'	'	101,234
Interest recognized on beneficial conversion feature of convertible debentures issued	'	'	'	'	175,000	'	'	175,000
Net loss	'	'	'	'	'	'	-3,475,892	-3,475,892
Balance at Oct. 31, 2009	'	'	2,391	'	38,744,398	'	-39,585,919	-839,130
Balance (in shares) at Oct. 31, 2009	'	'	238,989	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $6.50 per share	'	'	220	'	142,780	'	'	143,000
Common stock issued to officers, directors and consultants for services, $6.50 per share (in shares)	'	'	22,000	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $8.25 per share	'	'	2	'	1,236	'	'	1,238
Common stock issued to officers, directors and consultants for services, $8.25 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $10.00 per share	'	'	2	'	1,498	'	'	1,500
Common stock issued to officers, directors and consultants for services, $10.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants for services $12.00 per share	'	'	2	'	1,798	'	'	1,800
Common stock issued to officers, directors and consultants for services $12.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services $13.00 per share	'	'	2	'	1,948	'	'	1,950
Common stock issued to officers, directors and consultants, for services $13.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services $16.75 per share	'	'	2	'	2,511	'	'	2,513
Common stock issued to officers, directors and consultants, for services $16.75 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services $18.75 per share	'	'	40	'	74,960	'	'	75,000
Common stock issued to officers, directors and consultants, for services $18.75 per share (in shares)	'	'	4,000	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services $19.50 per share	'	'	200	'	389,800	'	'	390,000
Common stock issued to officers, directors and consultants, for services $19.50 per share (in shares)	'	'	20,000	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services $20.00 per share	'	'	199	'	398,801	'	'	399,000
Common stock issued to officers, directors and consultants, for services $20.00 per share (in shares)	'	'	19,950	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services $22.50 per share	'	'	3	'	6,747	'	'	6,750
Common stock issued to officers, directors and consultants, for services $22.50 per share (in shares)	'	'	300	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services $23.25 per share	'	'	1	'	3,486	'	'	3,487
Common stock issued to officers, directors and consultants, for services $23.25 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services, $24.00 per share	'	'	120	'	287,880	'	'	288,000
Common stock issued to officers, directors and consultants, for services, $24.00 per share (in shares)	'	'	12,000	'	'	'	'	'
Common stock issued to officers, directors and consultants, for services, $25.00 per share	'	'	1	'	3,749	'	'	3,750
Common stock issued to officers, directors and consultants, for services, $25.00 per share (in shares)	'	'	150	'	'	'	'	'
Common stock issued for loans, $25.00 per share	'	'	213	'	531,787	'	'	532,000
Common stock issued for loans, $25.00 per share (in shares)	'	'	21,280	'	'	'	'	'
Common stock issued in private placement offering, $8.75 per share	'	'	8	'	7,482	'	'	7,492
Common stock issued in private placement offering, $8.75 per share (in shares)	'	'	856	'	'	'	'	'
Common stock issued in private placement offering, $11.25 per share	'	'	22	'	25,418	'	'	25,440
Common stock issued in private placement offering, $11.25 per share (in shares)	'	'	2,261	'	'	'	'	'
Common stock issued in private placement offering, $14.60 per share	'	'	120	'	174,880	'	'	175,000
Common stock issued in private placement offering, $14.60 per share (in shares)	'	'	12,000	'	'	'	'	'
Common stock issued in private placement offering, $50.00 per share	'	'	1	'	4,999	'	'	5,000
Common stock issued in private placement offering, $50.00 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued for debt, $100.00 per share	'	'	16	'	29,002	'	'	29,018
Common stock issued for debt, $100.00 per share (in shares)	'	'	1,600	'	'	'	'	'
Common stock issued for debt, $20.00 per share	'	'	10	'	19,990	'	'	20,000
Common stock issued for debt, $20.00per share (in shares)	'	'	1,000	'	'	'	'	'
Common stock redeemed for cash, $20.00 per share	'	'	-15	'	-14,985	'	'	-15,000
Common stock redeemed for cash, $20.00 per share (in shares)	'	'	-1,500	'	'	'	'	'
Options and warrants granted to employees and consultants for services	'	'	'	'	67,890	'	'	67,890
Interest recognized on beneficial conversion feature of convertible debentures issued	'	'	'	'	96,664	'	'	96,664
Net loss	'	'	'	'	'	'	-3,080,464	-3,080,464
Balance at Oct. 31, 2010	'	'	3,560	'	41,004,719	'	-42,666,383	-1,658,104
Balance (in shares) at Oct. 31, 2010	'	'	355,886	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $2.00 per share	'	'	60	'	11,940	'	'	12,000
Common stock issued to officers, directors and consultants for services, $2.00 per share (in shares)	'	'	6,000	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $2.25 per share	'	'	1	'	224	'	'	225
Common stock issued to officers, directors and consultants for services, $2.25 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $2.505 per share	'	'	1	'	249	'	'	250
Common stock issued to officers, directors and consultants for services, $2.505 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $3.00 per share	'	'	180	'	53,820	'	'	54,000
Common stock issued to officers, directors and consultants for services, $3.00 per share (in shares)	'	'	18,000	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $4.10 per share	'	'	1	'	409	'	'	410
Common stock issued to officers, directors and consultants for services, $4.10 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $5.00 per share	'	'	71	'	35,179	'	'	35,250
Common stock issued to officers, directors and consultants for services, $5.00 per share (in shares)	'	'	7,050	'	'	'	'	'
Common stock issued for loan, $1.78 per share	'	'	12	'	2,128	'	'	2,140
Common stock issued for loan, $1.78 per share (in shares)	'	'	1,200	'	'	'	'	'
Common stock issued in private placement offering, $2.04 per share	'	'	80	'	16,328	'	'	16,408
Common stock issued in private placement offering, $2.04 per share (in shares)	'	'	8,033	'	'	'	'	'
Common stock issued in private placement offering, $2.47 per share	'	'	93	'	23,036	'	'	23,129
Common stock issued in private placement offering, $2.47 per share (in shares)	'	'	9,364	'	'	'	'	'
Common stock issued in private placement offering, $2.80 per share	'	'	44	'	12,233	'	'	12,277
Common stock issued in private placement offering, $2.80 per share (in shares)	'	'	4,381	'	'	'	'	'
Common stock issued in private placement offering, $2.85 per share	'	'	50	'	14,201	'	'	14,251
Common stock issued in private placement offering, $2.85 per share (in shares)	'	'	5,000	'	'	'	'	'
Common stock issued in private placement offering, $2.93 per share	'	'	24	'	6,900	'	'	6,924
Common stock issued in private placement offering, 2.93 per share (in shares)	'	'	2,360	'	'	'	'	'
Common stock issued in private placement offering, $3.00 per share	'	'	9	'	2,818	'	'	2,827
Common stock issued in private placement offering, $3.00 per share (in shares)	'	'	942	'	'	'	'	'
Common stock issued in private placement offering, $3.09 per share	'	'	40	'	12,310	'	'	12,350
Common stock issued in private placement offering, $3.09 per share (in shares)	'	'	4,000	'	'	'	'	'
Common stock issued in private placement offering, $3.18 per share	'	'	7	'	2,176	'	'	2,183
Common stock issued in private placement offering, $3.18 per share (in shares)	'	'	686	'	'	'	'	'
Common stock issued in private placement offering, $3.33 per share	'	'	8	'	2,562	'	'	2,570
Common stock issued in private placement offering, $3.33 per share (in shares)	'	'	773	'	'	'	'	'
Common stock issued in private placement offering, $6.51 per share	'	'	16	'	10,501	'	'	10,517
Common stock issued in private placement offering, $6.51 per share (in shares)	'	'	1,616	'	'	'	'	'
Common stock issued for debt, $0.20 per share	'	'	1,820	'	34,580	'	'	36,400
Common stock issued for debt, $0.20 per share (in shares)	'	'	182,000	'	'	'	'	'
Common stock issued for debt, $0.35 per share	'	'	714	'	24,286	'	'	25,000
Common stock issued for debt, $0.35 per share (in shares)	'	'	71,429	'	'	'	'	'
Common stock issued for debt, $0.38 per share	'	'	399	'	14,601	'	'	15,000
Common stock issued for debt, $0.38 per share (in shares)	'	'	39,920	'	'	'	'	'
Common stock issued for debt, $0.45 per share	'	'	289	'	12,711	'	'	13,000
Common stock issued for debt, $0.45 per share (in shares)	'	'	28,889	'	'	'	'	'
Common stock issued for debt, $0.65 per share	'	'	200	'	12,800	'	'	13,000
Common stock issued for debt, $0.65 per share (in shares)	'	'	20,000	'	'	'	'	'
Common stock issued for debt, $0.70 per share	'	'	543	'	37,457	'	'	38,000
Common stock issued for debt, $0.70 per share (in shares)	'	'	54,286	'	'	'	'	'
Common stock issued for debt, $0.80 per share	'	'	63	'	4,937	'	'	5,000
Common stock issued for debt, $0.80 per share (in shares)	'	'	6,250	'	'	'	'	'
Common stock issued for debt, $0.90 per share	'	'	282	'	25,094	'	'	25,376
Common stock issued for debt, $0.90 per share (in shares)	'	'	28,196	'	'	'	'	'
Common stock issued for debt, $1.05 per share	'	'	95	'	9,905	'	'	10,000
Common stock issued for debt, $1.05 per share (in shares)	'	'	9,524	'	'	'	'	'
Common stock issued for debt, $1.35 per share	'	'	74	'	9,926	'	'	10,000
Common stock issued for debt, $1.35 per share (in shares)	'	'	7,407	'	'	'	'	'
Common stock issued for debt, $1.45 per share	'	'	103	'	14,897	'	'	15,000
Common stock issued for debt, $1.45 per share (in shares)	'	'	10,345	'	'	'	'	'
Common stock issued for debt, $1.50 per share	'	'	80	'	11,920	'	'	12,000
Common stock issued for debt, $1.50 per share (in shares)	'	'	8,000	'	'	'	'	'
Common stock issued for debt, $1.65 per share	'	'	61	'	9,939	'	'	10,000
Common stock issued for debt, $1.65 per share (in shares)	'	'	6,061	'	'	'	'	'
Common stock issued for debt, $1.70 per share	'	'	164	'	27,701	'	'	27,865
Common stock issued for debt, $1.70 per share (in shares)	'	'	16,391	'	'	'	'	'
Common stock issued for debt, $1.75 per share	'	'	69	'	11,931	'	'	12,000
Common stock issued for debt, $1.75 per share (in shares)	'	'	6,857	'	'	'	'	'
Common stock issued for debt, $1.80 per share	'	'	83	'	14,917	'	'	15,000
Common stock issued for debt, $1.80 per share (in shares)	'	'	8,333	'	'	'	'	'
Common stock issued for debt, $1.95 per share	'	'	173	'	33,627	'	'	33,800
Common stock issued for debt, $1.95 per share (in shares)	'	'	17,333	'	'	'	'	'
Common stock issued for debt, $2.70 per share	'	'	37	'	9,963	'	'	10,000
Common stock issued for debt, $2.70 per share (in shares)	'	'	3,704	'	'	'	'	'
Common stock issued for debt, $3.02 per share	'	'	115	'	34,460	'	'	34,575
Common stock issued for debt, $3.02 per share (in shares)	'	'	11,467	'	'	'	'	'
Common stock issued for debt, $3.00 per share	'	'	60	'	17,940	'	'	18,000
Common stock issued for debt, $3.00 per share (in shares)	'	'	6,000	'	'	'	'	'
Common stock issued for debt, $3.70 per share	'	'	27	'	9,973	'	'	10,000
Common stock issued for debt, $3.70 per share (in shares)	'	'	2,703	'	'	'	'	'
Common stock issued for debt, $3.75 per share	'	'	40	'	14,960	'	'	15,000
Common stock issued for debt, $3.75 per share (in shares)	'	'	4,000	'	'	'	'	'
Options and warrants granted to employees and consultants for services	'	'	'	'	29	'	'	29
Interest recognized on beneficial conversion feature of convertible debentures issued	'	'	'	'	218,532	'	'	218,532
Net loss	'	'	'	'	'	'	-1,495,607	-1,495,607
Balance at Oct. 31, 2011	'	'	9,748	'	41,828,819	'	-44,161,990	-2,323,423
Balance (in shares) at Oct. 31, 2011	'	'	974,686	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.19 per share	'	'	42	'	4,958	'	'	5,000
Common stock issued to officers, directors and consultants for services, $1.19 per share (in shares)	'	'	4,202	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.21 per share	'	'	21	'	2,479	'	'	2,500
Common stock issued to officers, directors and consultants for services, $1.21 per share (in shares)	'	'	2,066	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.41 per share	'	'	35	'	4,965	'	'	5,000
Common stock issued to officers, directors and consultants for services, $1.41 per share (in shares)	'	'	3,546	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.46 per share	'	'	51	'	7,449	'	'	7,500
Common stock issued to officers, directors and consultants for services, $1.46 per share (in shares)	'	'	5,137	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.48 per share	'	'	34	'	4,966	'	'	5,000
Common stock issued to officers, directors and consultants for services, $1.48 per share (in shares)	'	'	3,378	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.51 per share	'	'	33	'	4,967	'	'	5,000
Common stock issued to officers, directors and consultants for services, $1.51 per share (in shares)	'	'	3,311	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.54 per share	'	'	33	'	4,967	'	'	5,000
Common stock issued to officers, directors and consultants for services, $1.54 per share (in shares)	'	'	3,247	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.56 per share	'	'	10	'	1,490	'	'	1,500
Common stock issued to officers, directors and consultants for services, $1.56 per share (in shares)	'	'	962	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.61 per share	'	'	31	'	4,969	'	'	5,000
Common stock issued to officers, directors and consultants for services, $1.61 per share (in shares)	'	'	3,106	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.65 per share	'	'	30	'	4,970	'	'	5,000
Common stock issued to officers, directors and consultants for services, $1.65 per share (in shares)	'	'	3,030	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.80 per share	'	'	1	'	179	'	'	180
Common stock issued to officers, directors and consultants for services, $1.80 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.78 per share	'	'	17	'	2,983	'	'	3,000
Common stock issued to officers, directors and consultants for services, $1.78 per share (in shares)	'	'	1,685	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.90 per share	'	'	18	'	3,482	'	'	3,500
Common stock issued to officers, directors and consultants for services, $1.90 per share (in shares)	'	'	1,842	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.95 per share	'	'	1	'	194	'	'	195
Common stock issued to officers, directors and consultants for services, $1.95 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.96 per share	'	'	400	'	77,900	'	'	78,300
Common stock issued to officers, directors and consultants for services, $1.96 per share (in shares)	'	'	40,000	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $2.75 per share	'	'	1	'	274	'	'	275
Common stock issued to officers, directors and consultants for services, $2.75 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $3.05 per share	'	'	1	'	304	'	'	305
Common stock issued to officers, directors and consultants for services, $3.05 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $3.25 per share	'	'	1	'	324	'	'	325
Common stock issued to officers, directors and consultants for services, $3.25 per share (in shares)	'	'	100	'	'	'	'	'
Common stock issued for loan, $2.74 per share	'	'	12	'	3,276	'	'	3,288
Common stock issued for loan, $2.74 per share (in shares)	'	'	1,200	'	'	'	'	'
Common stock issued in private placement offering, $0.50 per share	'	'	20,000	'	980,000	'	'	1,000,000
Common stock issued in private placement offering, $0.50 per share (in shares)	'	'	2,000,000	'	'	'	'	'
Common stock issued in private placement offering, $0.75 per share	'	'	800	'	59,200	'	'	60,000
Common stock issued in private placement offering, $0.75 per share (in shares)	'	'	80,000	'	'	'	'	'
Common stock issued in private placement offering, $1.36 per share	'	'	221	'	29,779	'	'	30,000
Common stock issued in private placement offering, $1.36 per share (in shares)	'	'	22,131	'	'	'	'	'
Common stock issued in private placement offering, $1.50 per share	'	'	692	'	103,175	'	'	103,867
Common stock issued in private placement offering, $1.50 per share (in shares)	'	'	69,244	'	'	'	'	'
Common stock issued in private placement offering, $1.90 per share	'	'	51	'	9,715	'	'	9,766
Common stock issued in private placement offering, $1.90 per share (in shares)	'	'	5,140	'	'	'	'	'
Common stock issued in private placement offering, $2.00 per share	'	'	106	'	21,090	'	'	21,196
Common stock issued in private placement offering, $2.00 per share (in shares)	'	'	10,598	'	'	'	'	'
Common stock issued in private placement offering, $2.66 per share	'	'	58	'	15,386	'	'	15,444
Common stock issued in private placement offering, $2.66 per share (in shares)	'	'	5,806	'	'	'	'	'
Common stock issued in private placement offering, $2.80 per share	'	'	120	'	33,421	'	'	33,541
Common stock issued in private placement offering, $2.80 per share (in shares)	'	'	11,979	'	'	'	'	'
Common stock issued for debt, $0.55 per share, net	'	'	191	'	10,309	'	'	10,500
Common stock issued for debt, $0.55 per share, net (in shares)	'	'	19,091	'	'	'	'	'
Common stock issued for debt, $0.60 per share, net	'	'	192	'	11,308	'	'	11,500
Common stock issued for debt, $0.60 per share, net (in shares)	'	'	19,167	'	'	'	'	'
Common stock issued for debt, $0.65 per share, net	'	'	505	'	20,147	'	'	20,652
Common stock issued for debt, $0.65 per share, net (in shares)	'	'	50,462	'	'	'	'	'
Common stock issued for debt, $0.70 per share, net	'	'	600	'	29,400	'	'	30,000
Common stock issued for debt, $0.70 per share, net (in shares)	'	'	60,000	'	'	'	'	'
Common stock issued for debt, $0.75 per share, net	'	'	1,269	'	52,678	'	'	53,947
Common stock issued for debt, $0.75 per share, net (in shares)	'	'	126,933	'	'	'	'	'
Common stock issued for debt, $0.80 per share, net	'	'	539	'	42,561	'	'	43,100
Common stock issued for debt, $0.80 per share, net (in shares)	'	'	53,875	'	'	'	'	'
Common stock issued for debt, $0.85 per share, net	'	'	176	'	14,824	'	'	15,000
Common stock issued for debt, $0.85 per share, net (in shares)	'	'	17,647	'	'	'	'	'
Common stock issued for debt, $0.95 per share, net	'	'	453	'	42,547	'	'	43,000
Common stock issued for debt, $0.95 per share, net (in shares)	'	'	45,263	'	'	'	'	'
Common stock issued for debt, $1.00 per share, net	'	'	2,970	'	294,065	'	'	297,035
Common stock issued for debt, $1.00 per share, net (in shares)	'	'	297,035	'	'	'	'	'
Common stock issued for debt, $1.49 per share, net	'	'	84	'	12,416	'	'	12,500
Common stock issued for debt, $1.49 per share, net (in shares)	'	'	8,400	'	'	'	'	'
Common stock issued for debt, $1.50 per share, net	'	'	452	'	67,375	'	'	67,827
Common stock issued for debt, $1.50 per share, net (in shares)	'	'	45,218	'	'	'	'	'
Common stock issued for debt, $1.75 per share, net	'	'	4,382	'	762,442	'	'	766,824
Common stock issued for debt, $1.75 per share, net (in shares)	'	'	438,185	'	'	'	'	'
Common stock issued for debt, $2.00 per share, net	'	'	285	'	56,715	'	'	57,000
Common stock issued for debt, $2.00 per share, net (in shares)	'	'	28,500	'	'	'	'	'
Common stock issued for debt, $3.50 per share, net	'	'	71	'	24,929	'	'	25,000
Common stock issued for debt, $3.50 per share, net (in shares)	'	'	7,143	'	'	'	'	'
Options and warrants granted to employees and consultants for services	'	'	'	'	231,616	'	'	231,616
Net loss	'	'	'	'	'	'	-1,249,491	-1,249,491
Balance at Oct. 31, 2012	'	'	44,737	'	44,889,013	'	-45,411,481	-477,731
Balance (in shares) at Oct. 31, 2012	'	'	4,473,715	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.63 per share	'	'	4	'	705	'	'	709
Common stock issued to officers, directors and consultants for services, $1.63 per share	'	'	435	'	'	'	'	'
Common stock issued to officers, directors and consultants for services, $1.45 per share	'	'	2	'	282	'	'	284
Common stock issued to officers, directors and consultants for services, $1.45 per share	'	'	196	'	'	'	'	'
Common stock issued in private placement offering, $0.50 per share	'	'	3,700	'	181,300	'	'	185,000
Common stock issued in private placement offering, $0.50 per share (in shares)	'	'	370,000	'	'	'	'	'
Common stock issued in private placement offering, $0.75 per share	'	'	134	'	9,866	'	'	10,000
Common stock issued in private placement offering, $0.75 per share (in shares)	'	'	13,333	'	'	'	'	'
Common stock issued in private placement offering, $1.50 per share	'	'	33	'	4,967	'	'	5,000
Common stock issued in private placement offering, $1.50 per share (in shares)	'	'	3,333	'	'	'	'	'
Common stock issued in private placement offering, $0.85 per share	'	'	2,118	'	177,882	'	'	180,000
Common stock issued in private placement offering, $0.85 per share (in shares)	'	'	211,765	'	'	'	'	'
Common stock issued for debt, $0.575 per share, net	'	'	240	'	13,559	'	'	13,799
Common stock issued for debt, $0.575 per share, net (in shares)	'	'	23,998	'	'	'	'	'
Common stock issued for debt, $1.00 per share, net	'	'	80	'	7,920	'	'	8,000
Common stock issued for debt, $1.00 per share, net (in shares)	'	'	8,000	'	'	'	'	'
Common stock issued for debt, $1.50 per share, net	'	'	80	'	11,920	'	'	12,000
Common stock issued for debt, $1.50 per share, net (in shares)	'	'	8,000	'	'	'	'	'
Common stock issued on exercise of options, $1.00 per share	'	'	400	'	39,600	'	'	40,000
Common stock issued on exercise of options, $1.00 per share (in shares)	'	'	40,000	'	'	'	'	'
Interest recognized on beneficial conversion feature of convertible debentures issued	'	'	'	'	-1,980	'	'	-1,980
Adjustment as a result of reverse stock split	'	'	3	'	-3	'	'	'
Adjustment as a result of reverse stock split, shares	'	'	252	'	'	'	'	'
Net loss	'	'	'	'	'	'	-998,350	-998,350
Balance at Oct. 31, 2013	'	'	$51,531	'	$45,335,031	'	($46,409,831)	($1,023,269)
Balance (in shares) at Oct. 31, 2013	'	'	5,153,027	'	'	'	'	'

Consolidated_Statements_of_Sto1

Consolidated Statements of Stockholders' (Deficit) (Parenthetical) (USD $)	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011	Oct. 31, 2010	Oct. 31, 2009	Oct. 31, 2008	Oct. 31, 2007	Oct. 31, 2006
Statement of Stockholders' Equity [Abstract]	'	'	'	'	'	'	'	'
Stock issued for convertible debt, per share	'	'	'	'	'	'	$0.25	$70
Stock and warrants issued for exchange of surrender subsidiary, per share	'	'	'	'	'	'	$150	$170
Stock issued for services, per share	$1.63	$1.19	$2	$6.50	$6	$175	$50	$40
Stock issued for services, per share	$1.45	$1.21	$2.25	$8.25	$7.69	$150	$80	$70
Stock issued for services, per share	'	$1.41	$2.50	$10	$7.75	$135	$120	$90
Stock issued for services, per share	'	$1.46	$3	$12	$8.83	$125	$0.25	$100
Stock issued for services, per share	'	$1.48	$4.10	$13	$9.31	$115	$150	$115
Stock issued for services, per share	'	$1.51	$5	$16.75	$20	$100	$160	$125
Stock issued for services, per share	'	$1.54	'	$18.75	$26.84	$90	$175	$130
Stock issued for services, per share	'	$1.61	'	$19.50	$28.09	$75	$200	$140
Stock issued for services, per share	'	$1.65	'	$20	$31.25	$70	$185	$170
Stock issued for services, per share	'	$1.80	'	$22.50	$35	$17.50	'	$225
Stock issued for services, per share	'	$1.78	'	$23.25	$44	$140	'	$170
Stock issued for services, per share	'	$1.90	'	$24	$45	$125	'	$255
Stock issued for services, per share	'	$1.95	'	$25	$55	$40	'	$170
Stock issued for services, per share	'	$1.96	'	'	$58.25	$135	'	$70
Stock issued for services, per share	'	$2.75	'	'	$70.25	$25	'	$170
Stock issued for services, per share	'	$3.05	'	'	$76	'	'	'
Stock issued for services, per share	'	$3.25	'	'	$77.25	'	'	'
Stock issued for loan, per share	'	'	'	$25	'	'	'	'
Stock issued for commission, per share	'	'	'	'	'	$200	$60	$250
Stock issued for former licensee debt, per share	'	'	'	'	'	'	$0.08	'
Stock issued upon exercise of warrants, per share	'	'	'	'	'	$30	'	'
Stock issued for settlement of lawsuit, per share	'	'	'	'	$37.40	'	'	'
Stock issued on excercise of option, per share	$1	'	'	'	'	'	'	'
Stock issued for private placement, per share	$0.50	$0.50	$2.04	$8.75	$25	$83.50	$60	'
Stock issued for private placement, per share	$0.85	$0.75	$2.47	$11.25	'	$60	$250	'
Stock issued for private placement, per share	$1.50	$1.36	$2.80	$14.60	'	'	'	'
Stock issued for private placement, per share	$0.75	$1.50	$2.93	$50	'	'	'	'
Stock issued for private placement, per share	'	$1.90	$3	'	'	'	'	'
Stock issued for private placement, per share	'	$2	$3.09	'	'	'	'	'
Stock issued for private placement, per share	'	$2.66	$3.18	'	'	'	'	'
Stock issued for private placement, per share	'	$2.80	$3.33	'	'	'	'	'
Stock issued for private placement, per share	'	'	$6.51	'	'	'	'	'
Common stock redeemed for cash, per share	'	'	'	$20	'	'	'	'
Stock issued for debt, per share	$1	$0.55	$0.20	$18	$4.50	$150	$100	'
Stock issued for debt, per share	$1.50	$0.60	$0.35	$20	$4.50	'	'	'
Stock issued for debt, per share	$0.57	$0.65	$0.38	'	$6.41	'	'	'
Stock issued for debt, per share	'	$0.70	$0.45	'	$22.77	'	'	'
Stock issued for debt, per share	'	$0.75	$0.65	'	'	'	'	'
Stock issued for debt, per share	'	$0.80	$0.70	'	'	'	'	'
Stock issued for debt, per share	'	$0.85	$0.80	'	'	'	'	'
Stock issued for debt, per share	'	$0.95	$0.90	'	'	'	'	'
Stock issued for debt, per share	'	$1	$1.05	'	'	'	'	'
Stock issued for debt, per share	'	$1.49	$1.35	'	'	'	'	'
Stock issued for debt, per share	'	$1.50	$1.45	'	'	'	'	'
Stock issued for debt, per share	'	$1.75	$1.50	'	'	'	'	'
Stock issued for debt, per share	'	$2	$1.65	'	'	'	'	'
Stock issued for debt, per share	'	$3.50	$1.70	'	'	'	'	'
Stock issued for debt, per share	'	'	$1.75	'	'	'	'	'
Stock issued for debt, per share	'	'	$1.80	'	'	'	'	'
Stock issued for debt, per share	'	'	$1.95	'	'	'	'	'
Stock issued for debt, per share	'	'	$2.70	'	'	'	'	'
Stock issued for debt, per share	'	'	$3.02	'	'	'	'	'
Stock issued for debt, per share	'	'	$3	'	'	'	'	'
Stock issued for debt, per share	'	'	$3.70	'	'	'	'	'
Stock issued for debt, per share	'	'	$3.75	'	'	'	'	'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended		96 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2013
Cash flows from operating activities:	'	'	'
Net loss	($998,350)	($1,249,491)	($18,600,630)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'
Depreciation and amortization	53,188	35,925	229,561
Gain on extinguishment of debt	'	-288,192	-288,192
Change in value of derivatives	-8,753	-55,195	-158,057
Change in anti-dilution liability	-42,043	'	-42,043
Amortization of costs and fees related to convertible debentures	32,999	235,817	1,418,094
Common stock issued for services	'	'	2,144,790
Common stock issued to officers, directors and consultants for services	993	132,796	3,212,484
Common stock issued for shares of subsidiary stock	'	'	254,000
Common stock of subsidiary issued to employees and consultants	'	'	2,815
Common stock issued as a commission	'	'	3,000
Common stock issued for accounts payable	'	'	296,583
Common stock issued to former licensee	'	'	41,319
Common stock issued/recovered on cancelled agreements	'	'	20,478
Non-cash compensation for stock options and warrants	'	'	631,923
Costs and fees related to issuance of convertible debt	'	3,288	542,540
Interest expense related to beneficial conversion feature	-1,980	'	1,942,820
Interest paid with common stock	'	'	118,487
Interest on notes receivable for common stock	'	'	-1,373
(Increase) decrease in assets:	'	'	'
Related party receivables	15,269	-15,269	'
Prepaid expenses	30,223	-30,900	24,694
Inventories	-41,887	-25,600	-143,275
Increase (decrease) in liabilities:	'	'	'
Trade accounts payable	184,794	-131,650	669,688
Accounts payable to officers and directors	85,889	92,541	838,512
Accrued payroll and other expenses	128,750	172,332	562,399
Net cash used in operating activities	-560,908	-1,123,598	-6,279,383
Cash flows from investing activities:	'	'	'
Purchase of fixed assets	-6,404	-79,789	-223,547
Capitalization of software	-35,313	'	-35,313
Net cash used in investing activities	-41,717	-79,789	-258,860
Cash flows from financing activities:	'	'	'
Principal payments on notes payable to stockholder	-28,300	-140,500	-1,301,800
Proceeds from issuance of notes payable to a related party	40,800	80,000	1,160,600
Proceeds from issuance of notes and convertible notes payable	85,000	75,000	1,689,234
Proceeds from issuance of common stock	420,000	1,273,813	3,875,475
Net cash provided by financing activities	517,500	1,288,313	5,423,509
Net change in cash	-85,125	84,926	-1,190,291
Cash at beginning of period	90,132	5,206	1,195,298
Cash at end of period	5,007	90,132	5,007
Supplemental Disclosure of Cash Flow Information	'	'	'
Interest paid	271	'	11,256
Income taxes paid	'	'	20,240
Supplemental Schedule of Non-Cash Investing and Financing Activities	'	'	'
Conversion of convertible notes payable to shares of common stock	12,500	395,000	'
Common stock issued in consideration for accounts payable and accrued payroll	20,000	680,804	'
Notes converted by stockholders	'	315,500	'
Interest paid with common stock	1,299	127,982	'
Common stock issued in consideration for loan	'	$3,288	'

Description_of_Business_and_De

Description of Business and Development Stage Company	12 Months Ended
	Oct. 31, 2013
Description Of Business And Development Stage Company	'
Description of Business and Development Stage Company	'
	1. Description of Business and Development Stage Company
	Micro Imaging Technology, Inc. (the “Company”), a California corporation, is a holding company whose operations are conducted through its 81%-owned subsidiary.
	The losses incurred to date which are applicable to the noncontrolling (minority) stockholders of the Company’s consolidated subsidiary, Micro Imaging Technology (MIT) exceed the value of the equity held by the noncontrolling stockholders. Such losses have been allocated to the Company as the majority stockholder and are included in the net loss and accumulated deficit in the consolidated financial statements for the fiscal year ended October 31, 2013. In accordance with the guidance provided under FASB Codification No. 810, (Consolidation-Noncontrolling Interests) the Company’s annual and interim reports present losses by the subsidiary separately from that attributable to the parent and separately in the equity section of the balance sheets.
	In 1997, the Company began marketing a small, point-of-use water treatment product aimed at the high purity segment of commercial and industrial water treatment markets. In February 2000, the Company formed Electropure EDI, Inc. (EDI), a wholly-owned Nevada subsidiary, through which all manufacturing and sales of its proprietary water treatment products were then conducted. In October 2005, the Company sold the assets of the EDI subsidiary and discontinued operations.
	The Company acquired, in October 1997, an exclusive license to patent and intellectual property rights involving laser light scattering techniques to be utilized in the detection and monitoring of toxicants in drinking water. The Company formed Micro Imaging Technology (MIT) in February 2000, a wholly-owned Nevada subsidiary, to conduct research and development based upon advancements developed and patented from the licensed technology. It is this technology that is being developed.
	The Company is developing a non-biologically based system utilizing both proprietary hardware and software to rapidly (near real time) determine the specific specie of an unknown microbe present in a fluid with a high degree of statistical probability (“MIT System”). It will analyze a sample presented to it and compare its characteristics to a library of known microbe characteristics on file. At present, it is the Company’s only operation.
	Effective with the sale of its EDI operation in October 2005, the Company’s planned principal operation, the further development and marketing of its remaining technology, has not produced any significant revenue and, as such, the Company, beginning with the fiscal year commenced November 1, 2005, is considered a development stage enterprise.

Basis_of_Presentation

Basis of Presentation	12 Months Ended
	Oct. 31, 2013
Basis Of Presentation	'
Basis of Presentation	'
	2. Basis of Presentation
	The Company incurred net losses from continuing operations of $998,350 and $1,249,491 for the fiscal years ended October 31, 2013 and 2012, respectively. At October 31, 2013 the Company had an accumulated deficit of $46,409,831 and is in default under the redemption provisions of its redeemable preferred stock (Note 7). These raise substantial doubts about the Company’s ability to continue as a going concern. The Company has been able to secure operating capital in the prior and current fiscal years through loans from an individual who is a related party and the largest stockholder, through the sale of convertible debentures and through the sale of the Company’s common stock in various private placement transactions.
	The Company is also negotiating with private accredited investors for the sale of its common stock in private placement transactions. No assurances can be given that the Company can or will continue to obtain sufficient working capital through the sale of the Company’s securities, borrowing, or through the sale of assets or products that will generate sufficient revenues in the future to sustain ongoing operations. The Company’s ability to continue as a going concern will be dependent upon its ability to gain access to equity and debt capital or achieve profitable operations.
	The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amount and classification of liabilities or any other adjustment that might be necessary should the Company be unable to continue as a going concern.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Oct. 31, 2013
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	3. Summary of Significant Accounting Policies
	Principles of Consolidation
	The accompanying consolidated financial statements include the accounts of the Company and its subsidiary, Micro Imaging Technology (“MIT”). As of October 31, 2005, the operations of the Company’s subsidiaries, Electropure EDI, Inc. and Electropure Holdings, LLC, were discontinued and the Company became a development stage company. All significant intercompany balances and transactions have been eliminated in consolidation.
	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual amounts could differ from those estimates.
	Changes in Capitalization and Reverse Stock Split
	On February 8, 2013, the Company amended its Articles of Incorporation and decreased the authorized number of shares of Common Stock from 2.5 billion to 25 million shares. At the same time, the Company underwent a five hundred-for-one (500:1) reverse stock split of its Common Stock and Redeemable Convertible Preferred Stock. For purposes of this Annual Report, all issuances of common stock and options or warrants to purchase common stock, if any, are reflected retroactively in post-reverse split amounts. As of October 31, 2013, the reverse split effected by the Company resulted in a reduction in capital stock and an increase in additional paid-in capital in the amount of $24,677,786.
	Cash and Cash Equivalents
	For purposes of reporting within the statement of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents.
	Impairment of Long-Lived Assets
	The Company annually evaluates its long-lived assets, including identifiable intangible assets for potential impairment. When circumstances indicate that the carrying amount of an asset is not recoverable, as demonstrated by the projected undiscounted cash flows, an impairment loss is recognized. The Company’s management has determined that there was no such impairment present at October 31, 2013 and 2012.
	Inventory
	Inventory is stated at the lower of cost or market. Cost is determined on a first-in, first-out (FIFO) basis. The Company’s management monitors inventory for excess and obsolete items and makes necessary valuation corrections when such adjustments are required.
	Property and Equipment
	Property and equipment are recorded at cost and are depreciated using the straight-line method over an expected useful life of 3 or 5 years. The leasehold improvements made to the Company’s leased facility are being depreciated over an expected useful life of 5 years. Expenditures for normal maintenance and repairs are charged to operations. The cost and related accumulated depreciation of assets are removed from the accounts upon retirement or other disposition, and the resulting profit or loss is reflected in the Statement of Operations. Renewals and betterments that materially extend the life of the assets are capitalized.
	The production tooling for the Company’s revised MIT 1000 has been capitalized and the $14,000 cost is being amortized over an estimated useful life of 3 years.
	Software Costs
	The Company capitalized $35,313 in fiscal 2013 in the development of proprietary software for the MIT 1000 rapid microbial identification system. The cost of the software is being amortized on a straight-line basis over 3 years.
	Advertising Costs
	The Company charges advertising costs to expense as incurred. The Company incurred $17,123 and $25,357 in advertising expense during the fiscal year ended October 31, 2013 and 2012, respectively.
	Accrued Payroll, Payroll Taxes and Benefits
	From April 2010 through March 2012, payments made to two employees were recorded as reductions in accrued and unpaid payroll. In April 2012, the Company reclassified such payments as net payroll payments; calculated and recorded the employer and employee taxes that should have been withheld on such payment. Federal and state payroll tax returns have been filed for the last three quarters of 2010, all of 2011 and the first quarter of 2012. The Company recorded a total of $81,206 and $20,560 in federal and state payroll taxes due, respectively. Estimated federal penalties and interest on the late filings and payments, in the sum of $24,196, have been accrued as of October 31, 2013. On September 20, 2012 and May 14, 2013, the Internal Revenue Service filed a Notice of Federal Tax Lien against the Company assessing $58,858 and $13,605, respectively for unpaid taxes, penalties and interest. The Company is in contact with the Internal Revenue Service to work out a payment schedule for the amounts due.
	Estimated state penalties and interest of $4,316 on the above late filings were accrued. A Notice of Tax Lien for a portion of the taxes due was filed by the State of California on November 9, 2012 in the amount of $8,206, including penalty and interest. In October 2013, the California tax authority levied the Company’s account in the sum of $13,807 with an additional levy of $5,451 in November 2013. On December 17, 2013, the Company entered into an installment agreement with the California tax authority to pay $304 per month commencing January 27, 2014 until the remaining balance due has been satisfied.
	Accrued Payroll and Benefits consist of the above payroll taxes, salaries, wages, and vacation benefits earned by employees, but not disbursed as of October 31, 2013 and includes payroll earned, but unpaid to various employees between January 16, 2013 and October 31, 2013. Accrued Payroll also includes the above estimated penalties and interest due on such unpaid payroll taxes. Liability for vacation benefits is accrued when earned monthly and reduced when taken. At the end of each fiscal period, the balance in the accrued vacation benefits liability account is adjusted to reflect current pay rates. Annual leave earned but not taken is considered an unfunded liability since this leave will be funded from future appropriations when it is actually taken by employees.
	Concentration of Credit Risk and Other Risks and Uncertainties
	Accounts Payable – Trade
	As of October 31, 2013, the amount due to a former consultant to the Company, $112,000, represented 33% of the total amount due for accounts payable to non-affiliates. As of October 31, 2013, the Company owed its current independent accounting firm $33,500, which represents 10% of the total amount due for accounts payable. An additional 19% of accounts payable, or $64,952, is due legal counsel in the Alpine MIT Partners litigation in Texas. The Company also owes local counsel $34,749 in accrued fees as of October 31, 2013, which represents 10% of the total amount due for accounts payable.
	Litigation and Claims
	Alpine MIT Partners
	On May 16, 2012, Alpine MIT Partners, LLC (Plaintiffs) filed a civil action against the Company and its Chairman and Chief Executive Officer, Jeffrey G. Nunez, (collectively, the Company), in the Texas District Court, Travis County. Plaintiffs alleged breach of contract and civil conspiracy, as well as tortious interference with contractual relations and prospective business relations. The lawsuit alleges that the Company breached certain provisions of a March 7, 2012 Securities Purchase Agreement the Company executed with the Plaintiff to sell up to $2.0 million of 7% Senior Secured five-year Convertible Debentures convertible into shares of common stock at a conversion rate of $.003 per share. The purchase and sale of the first $1.0 million Debenture was scheduled to close on or before April 6, 2012 and was subject to, among other things, Alpine closing the necessary equity funding to consummate the transactions. No money was ever received by the Company from Alpine. At a March 7, 2013 hearing, the Texas court upheld the Company’s argument and dismissed the complaint against the Company for lack of jurisdiction.
	In August, 2013, Alpine filed an amended Complaint against Jeffrey Nunez in the Texas case alleging tortuous interference and conspiracy to terminate the March 7, 2012 Securities Purchase Agreement. Mr. Nunez believes that the allegations of the lawsuit against him have no merit and intends to vigorously defend the matter.
	On January 10, 2013, the Company learned that Plaintiffs had filed a lien against the Company’s patents on May 8, 2012 with the California Secretary of State under the Uniform Commercial Code. On or about January 29, 2013, the Company filed suit against Alpine MIT Partners, LLC in the Orange County, California Superior Court alleging, among other claims, that the UCC filing is unauthorized. The lawsuit also names the managing director and managing member of Alpine as Defendants and alleges that they made false promises, intentional misrepresentations and breached the contract which is the subject of the Texas suit. The Company is seeking damages of $1.6 million. This lawsuit is currently in the discovery phase.
	Michael W. Brennan
	Concurrent with his April 13, 2012 resignation as Chairman of the Board of Directors and Chief Executive Officer, the Company agreed to repay a total of $160,000 in principal loans, $24,339 in accrued interest and $13,120 in unpaid fees and expenses due Michael Brennan over a 25-month payment schedule commencing May 1, 2012. Due to lack of funds, the Company has not made payments due Mr. Brennan since February 2013, each in the amount of $7,500. As of October 31, 2013, the principal balance due under the agreement amounted to $114,450 and, although Mr. Brennan originally waived interest on the note, the Company has accrued $11,750 in interest on that amount as of October 31, 2013.
	On or about October 4, 2013, Mr. Brennan filed a lawsuit in the California Superior Court of Los Angeles for breach of contract for failure to pay monies due him under the above 2012 agreement. The lawsuit seeks $123,509 in principal damages, plus interest, costs and attorney fees. The Company has filed an answer to the complaint and is contesting the amount due Mr. Brennan. This lawsuit is currently in the discovery phase.
	See also Item 13 – “Subsequent Events.”
	In accordance with accounting standards regarding loss contingencies, the Company accrues an undiscounted liability for those contingencies where the incurrence of a loss is probable and the amount can be reasonably estimated, and the Company discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for its financial statements not to be misleading. The Company does not record liabilities when the likelihood that the liability has been incurred is probable but the amount cannot be reasonably estimated, or when the liability is believed to be only reasonably possible or remote.
	Because litigation outcomes are inherently unpredictable, the Company’s evaluation of legal proceedings often involves a series of complex assessments by management about future events and can rely heavily on estimates and assumptions. If the assessments indicate that loss contingencies that could be material to any one of its financial statements are not probable, but are reasonably possible, or are probable, but cannot be estimated, then the Company discloses the nature of the loss contingencies, together with an estimate of the range of possible loss or a statement that such loss is not reasonably estimable. While the consequences of certain unresolved proceedings are not presently determinable, and an estimate of the probable and reasonably possible loss or range of loss in excess of amounts accrued for such proceedings cannot be reasonably made, an adverse outcome from such proceedings could have a material adverse effect on its financial statements in any given reporting period. However, in the opinion of Management, after consulting with legal counsel, the ultimate liability related to the current outstanding litigation is not expected to have a material adverse effect on its financial statements.
	Management is of the opinion that the ultimate resolution of such matters now pending will not have a material adverse effect on the Company’s consolidated results of operations, financial position or cash flows. However, the outcome of legal proceedings cannot be predicted with any degree of certainty.
	Antidilution Liability
	The Company has recorded a $23,358 liability to allow for the possible dilutive impact of equity issuances that alter or effect conversion or exchange rates existing on the various dates of conversion or exercise of securities having adjustable conversion rates. The liability is adjusted to reflect current fair market value at the end of each fiscal period. Due to the decline in the Company’s stock price, we recorded a gain of $42,043 at October 31, 2013.
	Research and Development
	Research and development expenditures are charged to expense as they are incurred. The Company’s research and development activities include ongoing work on various uses of the micro imaging multi-angle laser light scattering technology. Contract research and development expenditures are expensed as incurred.
	Stock Based Compensation
	The Company measures share based compensation at the grant date, based on the fair value of the award using the Black-Scholes Option Pricing Model, and recognizes such compensation as an expense over the employee’s requisite service period (generally the vesting period of the equity grant).
	The Company recognized no share-based compensation expense during the fiscal years ended October 31, 2013 and 2012.
	Activity under the Company’s stock option plans is included in Note 9.
	Income Taxes
	The Company accounts for income taxes under the liability method. Under the liability method, deferred income taxes are determined based on differences between the financial reporting and tax bases of assets and liabilities. They are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company is required to adjust its deferred tax liabilities in the period when tax rates or the provisions of the income tax laws change. Valuation allowances are established to reduce deferred tax assets to the amounts expected to be realized.
	The Company has not yet completed its state and federal corporate income tax returns for the fiscal year ended October 31, 2012, which were due to be filed (with an extension), by July 15, 2013. Neither has the Company paid the $1,600 state income tax due for fiscal 2012 or the estimated tax of $1,600 due to the state for the fiscal year ended October 31, 2013. The Company has accrued $1,150 as of October 31, 2013 as penalties and interest related to these late payments and filings.
	Loss Per Share
	Basic earnings (loss) per share excludes dilution and is calculated by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then share in the earnings (loss) of the entity. Common stock equivalents of 872,363 and 254,877 as of October 31, 2013 and 2012, respectively, have been omitted from the earnings (loss) per share calculation, as their effect would be antidilutive.
	New Accounting Pronouncements
	On January 31, 2013, the FASB issued Accounting Standards Update [ASU] 2013-01, entitled Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities. The guidance in ASU 2013-01 amends the requirements in the FASB Accounting Standards Codification [FASB ASC] Topic 210, entitled Balance Sheet. The ASU 2013-01 amendments to FASB ASC 210 clarify that ordinary trade receivables and receivables in general are not within the scope of ASU 2011-11, entitled Disclosure about Offsetting Assets and Liabilities, where that ASU amended the guidance in FASB ASC 210. As those disclosures now are modified with the ASU 2013-01 amendments, the FASB ASC 210 balance sheet offsetting disclosures now clearly are applicable only where reporting entities are involved with bifurcated embedded derivatives, repurchase agreements, reverse repurchase agreements, and securities borrowing and lending transactions that either are offset using the FASB ASC 210 or 815 requirements, or that are subject to enforceable master netting arrangements or similar agreements. ASU 2013-01 is effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. The adoption of this ASU is not expected to have a material impact on our financial statements.
	On February 28, 2013, the FASB issued Accounting Standards Update [ASU] 2013-04, entitled Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date. The ASU 2013-04 amendments add to the guidance in FASB Accounting Standards Codification [FASB ASC] Topic 405, entitled Liabilities and require reporting entities to measure obligations resulting from certain joint and several liability arrangements where the total amount of the obligation is fixed as of the reporting date, as the sum of the following:
		●	The amount the reporting entity agreed to pay on the basis of its arrangement among co-obligors.
		●	Any additional amounts the reporting entity expects to pay on behalf of its co-obligors.
	While early adoption of the amended guidance is permitted, for public companies, the guidance is required to be implemented in fiscal years, and interim periods within those years, beginning after December 15, 2013. The amendments need to be implemented retrospectively to all prior periods presented for obligations resulting from joint and several liability arrangements that exist at the beginning of the year of adoption. The adoption of ASU 2013-04 is not expected to have a material effect on the Company’s operating results or financial position.
	On April 22, 2013, the FASB issued Accounting Standards Update [ASU] 2013-07, entitled Liquidation Basis of Accounting. With ASU 2013-07, the FASB amends the guidance in the FASB Accounting Standards Codification [FASB ASC] Topic 205, entitled Presentation of Financial Statements. The amendments serve to clarify when and how reporting entities should apply the liquidation basis of accounting. The guidance is applicable to all reporting entities, whether they are public or private companies or not-for-profit entities. The guidance also provides principles for the recognition of assets and liabilities and disclosures, as well as related financial statement presentation requirements. The requirements in ASU 2013-07 are effective for annual reporting periods beginning after December 15, 2013, and interim reporting periods within those annual periods. Reporting entities are required to apply the requirements in ASU 2013-07 prospectively from the day that liquidation becomes imminent. Early adoption is permitted. The adoption of ASU 2013-07 is not expected to have a material effect on the Company’s operating results or financial position.
	On July 18, 2013, the FASB issued ASU 2013-11, which provides guidance on financial statement presentation of an unrecognized tax benefit2 when a net operating loss (NOL) carryforward, a similar tax loss, or a tax credit carryforward exists. The FASB’s objective in issuing this ASU is to eliminate diversity in practice resulting from a lack of guidance on this topic in current U.S. GAAP. This ASU applies to all entities with unrecognized tax benefits that also have tax loss or tax credit carryforwards in the same tax jurisdiction as of the reporting date. Under the ASU, an entity must present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, in the financial statements as a reduction to a deferred tax asset for an NOL carryforward, a similar tax loss, or a tax credit carryforward except when:
		●	An NOL carryforward, a similar tax loss, or a tax credit carryforward is not available as of the reporting date under the governing tax law to settle taxes that would result from the disallowance of the tax position.
		●	The entity does not intend to use the deferred tax asset for this purpose (provided that the tax law permits a choice).
	If either of these conditions exists, an entity should present an unrecognized tax benefit in the financial statements as a liability and should not net the unrecognized tax benefit with a deferred tax asset.
ASU 2013-11 is effective for public entities for fiscal years beginning after December 15, 2013, and interim periods within those years. The adoption of ASU 2013-11 is not expected to have a material effect on the Company’s operating results or financial position.
There were various other updates recently issued, many of which represented technical corrections to the accounting literature or application to specific industries. N one of the updates are expected to a have a material impact on our consolidated financial position, results of operations or cash flows.

Property_and_Equipment

Property and Equipment	12 Months Ended
	Oct. 31, 2013
Property, Plant and Equipment [Abstract]	'
Property and Equipment	'
	4. Property, Plant and Equipment
	At October 31, property, plant and equipment consisted of the following:
		2013			2012
	Machinery and equipment	$	235,504		$	229,100
	Furniture and fixtures		74,326			74,326
	Leasehold improvements		77,779			77,779
	Production molding		14,000			14,000
	Software		35,313			-
			436,922			395,205
	Less: accumulated depreciation		(325,352	)		(272,164	)
	Total property and equipment, net	$	111,570		$	123,041
	Depreciation and amortization expense for the years ended October 31, 2013 and 2012 was $53,188 and $35,925, respectively.

Convertible_Debentures

Convertible Debentures	12 Months Ended
	Oct. 31, 2013
Convertible Notes Payable [Abstract]	'
Convertible Debentures	'
	5. Convertible Debentures
	Series 1 Notes
	Under the provisions of ASC 815-40-15, “Derivatives and Hedging-Contracts in Entity’s Own Equity-Scope and Scope Exceptions,” a number of our outstanding Convertible notes are not considered indexed to our stock, as a result of an anti-dilution protection provision in these notes. The application of ASC 815-40-15, effective August 1, 2011, resulted in our accounting for these notes as derivative instruments, and they are recognized as liabilities in our consolidated balance sheets.
	Between August 16, 2010 and February 21, 2012, the Company entered into a Securities Purchase Agreement with an unaffiliated lender in connection with the issuance of eleven (11) separate 8% convertible notes in various principal amounts, aggregating $387,500. As of September 14, 2012, the lender had converted all of the $387,500 in principal notes, plus $45,000 and $15,500 in principal penalties and accrued interest, respectively, on such notes and received a total of 663,219 shares of common stock upon the conversions at prices ranging from $0.20 to $1.95 per share.
	On July 18, 2013 and September 18, 2013, the Company entered into new Securities Purchase Agreements with the lender, each in the sum of $42,500, and paid a total of $5,000 out of the proceeds of the notes to lender for legal fees and expenses related to the referenced agreements. The notes mature on April 22, 2014 and June 20, 2014, respectively, and are convertible into shares of common stock at a discount of 39% of the average of the lowest three closing bid prices of the common stock during the ten trading days prior to the conversion date. The Series I Notes contain a provision requiring an adjustment to the conversion price of the note in the event the Company issues or sells any shares of common stock, or securities convertible into or exercisable for common stock, at a price per share lower than such conversion price. Accordingly, the Series I Notes are accounted for as a derivative liability, measured at fair value, with changes in fair value recognized as gain or loss for each reporting period thereafter. The notes were recorded at fair value, using the Binomial valuation model, and a derivative liability of $75,557 has been recorded for the fiscal period ended October 31, 2013. This liability will be revalued each reporting period and gains and losses will be recognized in the statement of operations under “Other Income (Expense)”.
	Pursuant to the terms of the Series I Notes, the Company has instructed its stock transfer agent to reserve 1,400,000 shares of the Company’s common stock to be issued if the notes are converted. Such shares have been reserved, but are not considered as issued and outstanding. If the Series I Notes had been converted as of October 31, 2013, the Company would have issued a total of 348,360 shares of common stock the value of which would exceed, by $89,180 the principal balance due on the note.
	See also Note 13 – “Subsequent Events.”
	Fair value of financial instruments
	The accounting standards regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company. The Company considers the carrying amount of cash and other current assets and liabilities to approximate their fair values because of the short period of time between the origination of such instruments and their expected realization.
	The Company has also adopted ASC 820-10 (“Fair Value Measurements”) which defines fair value, establishes a three-level valuation hierarchy for disclosures of fair value measurement and enhances disclosure requirements for fair value measures. The three levels are defined as follows:
	● Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
	● Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
	● Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.
	The carrying amounts of our financial instruments, including cash, accounts payable and accrued expenses approximate fair value because of their generally short maturities.
	The Company measured the fair value of the Series 1 Note by using the Binomial Valuation model. As of October 31, 2013, the assumptions used to measure fair value of the liability embedded in our outstanding Series I Note included an exercise price of $0.31 per share, a common share price of $0.50, a discount rate of 0.08%, and a volatility of 138%.
	The following table sets forth, by level within the fair value hierarchy, our financial instrument liabilities as of October 31, 2013 (See also Note 6 – Convertible Debentures – “Series 1 Notes”):
		Quoted			Significant		Significant		Total
		Prices in			Other		Unobservable
		Active Markets For Identical Assets			Observable		Inputs
					Inputs
		(Level 3)			(Level 3)		(Level 3)
	Derivative liability	$	—		$	—	$	75,557	$	75,557
	Total	$	—		$	—	$	75,557	$	75,557
	The following table sets forth a summary of changes in the fair value of our Level 3 financial instrument liability for the fiscal years ended October 31, 2012 and 2013:
		Fair Value
		Measurements
		Using
		Significant
		Unobservable
		Inputs
		(Level 3)
	Balance October 31, 2012	$	-
	Additions		84,310
	Net gain included in earnings		(8,753	)
	Settlements		-
	Balance October 31, 2013	$	75,557
	Other Convertible Notes
	On November 10, 2010, the Company entered into a convertible note for $64,868 with a stockholder. The Note matured on May 31, 2012 and bears interest at the rate of ten percent (10%) per annum. The Note is convertible into shares of common stock at a forty two percent (42%) discount to the average of the lowest three (3) closing bid prices of the common stock during the ten (10) trading days prior to the conversion date. The note holder may convert any or all of the unpaid principal note prior to the maturity date. The Company calculated the intrinsic value of the conversion feature to be $46,973 as of the date of issuance of the debentures using the same criteria as noted above, which amount was fully amortized as of July 31, 2012. The Company has expensed $19,300 in accrued interest on the note as of October 31, 2013. If the note had been converted as of October 31, 2013, the Company would have issued a total of 279,603 shares of common stock the value of which would exceed, by $74,934 the principal balance due on the note. The Company is currently negotiating with the lender to settle or renegotiate the Note.
	On November 27, 2009, the Company borrowed $25,000 from an unaffiliated lender. In September 2011, the lender converted $12,500 of the principal and $2,876 in accrued interest into 17,084 shares of common stock. The Company issued an Amended and Restated Convertible Note for the $12,500 principal balance of the loan bearing 6% annual interest. The amended note matured on December 31, 2012 and on June 15, 2013, the lender converted the remaining $12,500 principal plus $1,299 in accrued interest into 23,998 shares of common stock at a conversion rate of $0.575 per share. Because the original note carried a beneficial conversion feature, the Company amortized a total of $10,507 as the intrinsic value of the note, including $3,202 which was expensed during fiscal 2013.
	At October 31, 2013 and 2012, without taking into effect any unamortized discounts, convertible debentures and Series 1 notes consisted of the following:
		2013			2012
	Series 1 Notes, principal and interest at 8% maturing through May 25, 2012.	$	85,000		$	—
	Convertible note payable to stockholder; principal and interest at 10% due on May 31, 2012.	$	64,868		$	64,868
	Convertible notes payable to various stockholders; principal and interest at 6% due on August 1, 2012 and December 31, 2012.	$	—		$	12,500
			149,868			77,368
	Less current maturities	$	149,868		$	77,368
	Long term portion of Convertible and Series 1 notes payable	$	—		$	—
	Of the above notes, $64,868 is currently due and payable. The Company’s outstanding notes mature as follows for the years ending October 31:
	2014		$	85,000
	Thereafter			—
			$	85,000

Notes_Payable_to_an_Officer_an

Notes Payable to an Officer and Stockholder	12 Months Ended
	Oct. 31, 2013
Debt Disclosure [Abstract]	'
Notes Payable to an Officer and Stockholders	'
	6. Notes Payable to an Officer and Stockholders
	At October 31, 2012 and 2011, without taking into effect any unamortized discounts, notes payable to an officer and to stockholders consisted of the following:
		2013			2012
	Unsecured, interest-free convertible notes payable to former officer/director of the Company; principal due on payment schedule through May 2014.	$	113,450		$	136,950
	Unsecured notes payable to officers/directors of the Company; principal and interest at 6% due on demand.	$	36,000		$	—
	Unsecured convertible note payable to various stockholders; principal and interest at 6% due between December 9, 2010 and March 31, 2013.	$	52,000		$	52,000
			201,450			188,950
	Less current maturities	$	201,450		$	142,844
	Long term portion of notes payable	$	—		$	46,106
	Of the above notes payable, $113,450 is the subject of a lawsuit brought against the Company by former officer and director, Michael Brennan. The Company is currently negotiating with the holders of $52,000 of the above notes to either extend the maturity date or convert the notes into shares of common stock. The Company’s outstanding notes mature as follows for the years ending:
	2014		$	201,450
	Thereafter			—
			$	201,450

Income_Taxes

Income Taxes	12 Months Ended
	Oct. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	7. Income Taxes
	At October 31, the components of the income tax expense are as follows:
		2013			2012
	Current tax expense:
	Federal	$	—		$	—
	State		1,600			1,600
	Total corporate tax expense		1,600			1,600
	Deferred tax expenses:
	Federal		—			—
	State		—			—
			—			—
	Total provision:	$	1,600		$	1,600
	Significant components of the Company’s net deferred income tax assets/ (liabilities) at October 31, 2013 were as follows:
	Current deferred tax assets:
	Accrued vacation	$	—
	Book compensation for options and warrants		—
	Other		—
	Total current deferred tax assets		—
	Valuation allowance		—
	Net deferred current tax assets	$	—
	Noncurrent deferred tax assets:
	Net operating loss carryforward	$	10,782,000
	Other credit carryforward		165,000
	Depreciation and amortization		—
	Total noncurrent deferred tax assets		10,947,000
	Valuation allowance		(10,947,000	)
	Net deferred noncurrent tax assets		—
	Total deferred tax assets	$	—
	The Company, based upon its history of losses and management’s assessment of when operations are anticipated to generate taxable income, has concluded that it is more likely than not that none of the net deferred income tax assets will be realized through future taxable earnings and has established a valuation allowance for them. The change in the total valuation allowance for the year ended October 31, 2013 was an increase of $396,000.
	Reconciliation of the effective income tax rate to the U.S. statutory income tax rate is as follows:
		2013			2012
	Tax expense at U.S. statutory income tax rate		(34.0	)%		(34.0	)%
	State tax		(5.8	)%		(5.8	)%
	Utilization of net operating loss		0	%		0	%
	Change in beginning balance of valuation allowance		39.8	%		39.8	%
	Effective income tax rate		—	%		—	%
	As of October 31, 2013, the Company has federal and state net operating loss carryforwards of $27,091,000 and $21,561,000, respectively. The federal and state net operating loss carryforwards begin expiring through 2013 and 2023. The Company also has federal and state research and development tax credit carryforwards of $165,000 and $130,000, respectively.
	Management regularly evaluates the likelihood of realizing the benefit for income tax positions taken by the Company in various federal and state filings by considering all relevant facts, circumstances and information available. If management believes it is more likely than not that a position will be sustained, the Company will recognize a benefit at the largest amount which is cumulatively greater than 50% likely to be realized. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as a component of the provision for income taxes. The Company has not recognized any contingencies for uncertain tax positions for the years ended October 31, 2013 and 2012. Although, the IRS is not currently examining any of the Company’s income tax returns, tax years 2009 through 2013 remain open and are subject to examination.

Stockholders_Deficit

Stockholders' Deficit	12 Months Ended
	Oct. 31, 2013
Stockholders' Equity Note [Abstract]	'
Stockholders' Deficit	'
	8. Stockholders’ Deficit
	Common Stock
	On November 29, 2012, the Company issued 200,000 shares of common stock to Gregg Newhuis, a Director of the Company, for proceeds of $100,000, or $0.50 per share.
	On January 11, 2013, a major stockholder of the Company exercised a warrant to purchase 40,000 shares of common stock at $1.00 per share and the Company received $40,000 pursuant to the exercise.
	On January 11, 2013, the Company’s Chief Financial Officer, Victor Hollander, purchased 3,333 shares of Common Stock for proceeds of $5,000, or $1.50 per share.
	Between January 16, 2013 and February 22, 2013, the Company issued a total of 16,000 shares of common stock in payment for legal services rendered valued at $20,000.
	Between February 6, 2013 and April 3, 2013, the Company issued a total of 211,764 to a major stockholder for proceeds of $180,000, or $0.85 per share. This same stockholder purchased an additional 60,000 shares of common stock for $30,000, or $0.50 per share, on August 13, 2013.
	On April 26, 2013, the Company issued 435 and 196 shares of common stock to Jeffrey Nunez at $1.63 and $1.45 per share, respectively, in partial payment of previous transaction fees due him pursuant to an April 2012 agreement whereby he received a 5% transaction fee on all monies received by the Company.
	On June 4, 2013, the Company sold 50,000 shares of common stock to a major stockholder for proceeds of $25,000, or $0.50 per share. As partial consideration for the transactions, the stockholder also received a three year warrant to purchase 50,000 shares of common stock at $0.50 per share and warrants to purchase 100,000 shares of common stock at $1.00 per share.
	Between August 7, 2013 and October 17, 2013, the above-referenced major stockholder purchased an additional 40,000 shares of common stock at $0.50 per share, for proceeds of $20,000. The stockholder also received six-month warrants purchase an additional 20,000 shares of common stock for $1.00 per share.
	On June 15, 2013, a stockholder converted a $12,500 principal loan, plus $1,299 in accrued interest, into 23,998 shares of common stock at $0.575 per share. And on June 28, 2013, this same stockholder purchased 13,333 shares of common stock from the Company for proceeds of $10,000, at $0.75 per share.
	On September 5, 2013, an unaffiliated investor purchased 20,000 shares of common stock at $0.50 per share for total proceeds of $10,000.
	Redeemable Preferred Stock
	The redeemable preferred stock, issued in 1987 to the then holders of the common and Class B common stock, had a redemption date in 1991. The redeemable preferred stock has not been redeemed due to a lack of “legally available funds.” These shares must be redeemed by the Company as soon as possible for $0.01 per share at any time the Company has the “legally available funds” for the redemption. There was a conversion feature to this redeemable preferred stock, which, with the passing of time, has lapsed. The Company believes the definition of “legally available funds” to be the amount under California law from which dividends could be paid by a corporation that does not have retained earnings. In general, California law provides that to the extent a corporation’s assets, excluding intangible and deferred assets, are at least equal to (a) the amount of the proposed distribution, and (b) 1.25 times its liabilities, excluding deferred taxes, deferred income, and deferred credits, a corporation may pay dividends. Under this definition, the Company had “legally available funds” as of October 31, 2000 and 1999. As a result, the Company is in default under the redemption provisions of the redeemable preferred stock.
	The redeemable preferred stock is not assignable or transferable, except upon death or upon approval of a majority of the members of the Board of Directors not holding such shares and is not entitled to receive any dividends.
	Preferred Stock
	The Company is authorized to issue 1,000,000 shares of Preferred Stock, $1.00 par value. The terms of the Preferred Stock, or any series thereof, may be determined from time to time by the Board of Directors. Such shares may be convertible into Common Stock and may have rank superior to the Common Stock in the payment of dividends, liquidation rights, voting and other rights, preferences and privileges. Future shares of Preferred Stock may be issued by the Company without submitting a proposal regarding the issuance of such shares to a vote of holders of Common Stock. The Company in the future could issue Preferred Stock in a situation designed to discourage a tender offer. The Company has no present plans to issue any shares of Preferred Stock.
	In January 2001, the Board of Directors authorized 250,000 shares of Series C preferred stock. Each share of Series C preferred stock is convertible at the option of the holder into four (4) shares of common stock. As of October 31, 2012, there were no shares of Series C preferred stock issued or outstanding.
	Also in January 2001, the Board of Directors authorized 500,000 shares of Series D preferred stock each of which is convertible into two (2) shares of common stock at the option of the holder. There were no shares of Series D preferred stock issued or outstanding at October 31, 2012.
	Voting Rights
	Each share of the Company’s common stock and redeemable preferred stock is entitled to one vote per share. Shares of the Company’s Series C and Series D convertible preferred stock carry no voting rights.
	Liquidation Preferences
	In the event of liquidation or dissolution of the Company, the holders of the common stock and redeemable preferred stock shall be entitled to receive an equal amount per share, provided, however, in no instance shall a share of redeemable preferred stock receive more than $0.01 per share.
	In any liquidation or dissolution of the Company, the holder of the Series C convertible preferred stock will be entitled to a liquidation preference of $4 per share.
	In any liquidation or dissolution of the Company, the holder of the Series D convertible preferred stock will be entitled to a liquidation preference of $2 per share.

Stock_Options_and_Warrants

Stock Options and Warrants	12 Months Ended
	Oct. 31, 2013
Stock Options And Warrants	'
Stock Options and Warrants	'
	9. Stock Options and Warrants
	Common Stock Options
	On February 14, 2012 the Board of Directors authorized the formation of the 2012 Employee Benefit Plan which is authorized to grant up to 120,000 shares of common stock or options to purchase common stock to eligible employees, directors, officers, consultants or advisors. Eligibility is determined by the Board of Directors. During the fiscal year ended October 31, 2013, the Company issued 16,000 shares of common stock under the Benefit Plan to legal counsel for services rendered in the aggregate sum of $20,000. Under the 2012 Plan, there are still 44,500 options or shares available to be issued. See Note 8 – “Common Stock.”
	The following table summarizes information about options granted under the Company’s equity compensation plans and otherwise to employees, directors and consultants of the Company. Generally, options vest on an annual pro rata basis over various periods of time and are exercisable, upon proper notice, in whole or in part at any time upon vesting. Typically, unvested options terminate when an employee leaves the Company. The options granted have contractual lives ranging from three to ten years.
				Number of				Weighted			Weighted			Aggregate
				Options				Average			Average			Intrinsic
								Exercise			Remaining			Value
								Price			Contractual
											Term
											(in years)
	Outstanding at October 31, 2011				6,000			$	45			2.1		$	—
	Granted				—				—
	Exercised				—				—
	Expired				(400	)			80
	Canceled				—				—
	Outstanding at October 31, 2012				5,600				40			1.2		$	—
	Granted				—				—
	Exercised				—				—
	Expired				(1,200	)			145.83
	Canceled				—				—
	Outstanding at October 31, 2013				4,400			$	13.35			0.4		$	—
	The values of the consideration received were based on the values of the options granted. The values of the options were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions for grants made in 2013 and 2012.
				2013				2012
	Risk-free interest rate			—				—	%
	Expected dividend yield			—				—
	Expected stock price volatility			—				—
	Expected life in years			—				—
	Summary information about the Company’s options outstanding at October 31, 2013 is set forth in the table below. Options outstanding at October 31, 2013 expire between February 2014 and January 2016.
	Range of				Options				Weighted			Weighted			Options			Weighted
	Exercise				Outstanding				Average			Average			Exercisable			Average
	Prices				October 31, 2013				Remaining			Exercise Price			October 31, 2013			Exercise
									Contractual Life									Price
	$	7.69				4,000				0.3		$	7.69			4,000		$	7.69
	$	70				400				2.2		$	70			400		$	70
	TOTAL:					4,400										4,400
	There were no unvested stock options as of October 31, 2013. See also Note 14 – “Subsequent Events.”
	Common Stock Warrants
	The Company accounts for stock-based compensation awards to non-employees based upon fair values at the grant dates. The consideration received for the issuance of stock purchase warrants (“warrants”) is based on the fair value of the warrants or of the goods or services received for the warrants issued, whichever is more reliably measurable.
	When the value of the services is based on the fair value of the warrants, the value is calculated using the Black-Scholes Option Pricing Model. The fair value of the options or warrants is expensed as the services are provided.
	As of October 31, 2013, of 146,667 warrants outstanding at the end of fiscal year 2012, 66,667 warrants were surrendered and cancelled and 40,000 warrants were exercised. During the fiscal year ended October 31, 2013, the Company granted warrants as follows:
	On June 4, 2013, as partial consideration for his purchase of 50,000 shares of common stock for $25,000, a major stockholder received three-year warrants to purchase an additional 50,000 shares of common stock at $0.50 per share and another 100,000 shares of common stock at $1.00 per share.
	On August 7, 2013, the above major stockholder received a six-month warrant to purchase 10,000 shares of common stock at $1.00 per share as consideration for a $10,000 purchase of stock at $0.50 per share.
	On October 17, 2013, the Company issued six-month warrants to purchase an additional 10,000 shares of common stock to the same stockholder for $1.00 per share for a similar $10,000 purchase of common stock.
	On August 13, 2013, a major stockholder received six-month warrants to purchase 30,000 shares of common stock at $1.00 per share as partial consideration for a $30,000 purchase of common stock at $0.50 per share.
	The following table summarizes the information relating to warrants granted to non-employees as of October 31, 2013 and 2012 and changes during the years then ended. Warrants outstanding at October 31, 2013 expire between February 2014 and June 2016.
	See also Note 13 – “Subsequent Events.”
				Number of				Weighted
				Warrants				Average
								Exercise
								Price
	Outstanding at October 31, 2011				10,000			$	5
	Granted				413,334				1
	Exercised				—				—
	Cancelled				(266,667	)			1.5
	Expired				(10,000	)			5
	Outstanding at October 31, 2012				146,667				1
	Granted				200,000				0.88
	Exercised				(40,000	)			1
	Cancelled				(66,667	)			1.5
	Expired				—				—
	Outstanding at October 31, 2013				240,000			$	0.9
	The values of the consideration received were based on the values of the warrants granted. The values of the warrants were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions for grants made in 2013 and 2012:
			2013				2012
Risk-free interest rate			0.71	%			0.72	%
Expected dividend yield			—				—
Expected stock price volatility			1.42				1.89
Expected life in years			2.0 years				1.7 years
Summary information about the Company’s warrants outstanding at October 31, 2013 is as follows:
Range of			Warrants				Weighted			Weighted			Warrants			Weighted
Exercise			October 31, 2013				Average			Average			Exercisable			Average
Prices							Remaining			Exercise			October 31, 2013			Exercise
							Contractual			Price						Price
							Life
$0.50				50,000				2.6		$	0.5			50,000		$	0.5
$1.00				190,000				1.8		$	1			190,000		$	1
TOTAL:				240,000										240,000

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Oct. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	10. Commitments and Contingencies
	Facilities Agreement
	In January 2006, the Company entered into a one-year agreement to lease a 4,100 sq. ft. facility in San Clemente, California at a rate of $3,650 per month commencing on April 1, 2006. The lease provides the Company with an option to extend the lease for additional one-year terms through March 31, 2012. The monthly lease payment increased to $3,895 commencing on April 1, 2008. The Company has signed an extension of the lease through March 2014 at the same monthly rate.
	Future minimum facilities lease payments as of October 31, 2013 are as follows:
	2014	$	19,475
	2015	$	—
	Employment Contracts
	Jeffrey Nunez
	On April 1, 2012, the Company entered into a one-year Consulting Agreement with Mr. Nunez which provides for compensation of $8,000 per month during the term of the agreement. On April 20, 2012, Mr. Nunez was appointed to the Board of Directors and named Chief Executive Officer of the Company. Effective October 1, 2012, the Board of Directors increased Mr. Nunez’ monthly compensation to $12,000. In October 2012, Mr. Nunez also received a bonus in the amount of $20,000 and 40,000 shares of the Company’s common stock valued at $78,300.
	Pursuant to the consulting arrangement, Mr. Nunez was entitled to a 5% “transaction fee” on all proceeds received by the Company during the term of the agreement, payable in common stock of the Company. Mr. Nunez received fees aggregating $60,000 pursuant to this provision on monies received through January 31, 2013, at which time this arrangement was terminated by mutual consent.

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Oct. 31, 2013
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	11. Related Party Transactions
	See Notes 6, 8, 9, 10, and 13 for related party transactions.

Employee_Retirement_Plan

Employee Retirement Plan	12 Months Ended
	Oct. 31, 2013
Compensation and Retirement Disclosure [Abstract]	'
Employee Retirement Plan	'
	12. Employee Retirement Plan
	Commencing on January 1, 2005, the Company sponsored a Simple IRA retirement plan which covers substantially all qualified full-time employees. Participation in the plan is voluntary, and employer contributions are determined on an annual basis. Currently employer contributions are being made at the rate of 3% of the employees’ base annual wages. No contributions to the IRA plan were made during fiscal 2012 or 2013.

Subsequent_Events_Unaudited

Subsequent Events (Unaudited)	12 Months Ended
	Oct. 31, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	13. Subsequent Events (Unaudited)
	On or about November 12, 2013, the Company was served with a Complaint brought in the Superior Court of Orange County, California by a vendor for non-payment of $9,894 in services performed. The Company has not contested the amount due and expects to negotiate a payment arrangement with the vendor in the near future.
	On November 8, 2013 and on December 13, 2013, the Company issued 20,000 shares of common stock to a major stockholder for proceeds of $20,000, or $0.50 per share. The stockholder also received six-month warrants to purchase an additional 20,000 shares of common stock at $1.00 per share.
	On November 13, 2013, the Company’s Chief Scientist, David Haavig, purchased 100,000 shares of common stock for $0.50 per share, or $50,000.
	On December 19, 2013, a major stockholder purchased 20,000 shares of common stock for proceeds of $10,000, or $0.50 per share. He received six-month warrants to purchase an additional 10,000 shares of common stock at $1.00 per share as part of the purchase transaction.
	On November 19, 2013, the Company established the 2014 Employee Benefit Plan (the “Plan”) which authorizes the issuance of up to 525,000 shares, or options underlying shares, to eligible employees, consultants or advisors of the Company. On November 19, 2013, the Board of Directors granted three-year options to purchase 100,000 and 125,000 shares of common stock under the Plan to the Company’s President, Jeffrey Nunez, at exercise prices of $0.50 and $1.00 per share, respectively. Additional three-year options to purchase 175,000 shares of common stock at $1.00 per share were also granted under the Plan to three other employees of the Company on November 19, 2013.
	Between November 8, 2013 and January 29, 2014, Gregg Newhuis, a member of the Board of Directors, loaned the Company $34,000. The loans bear interest at the rate of 6% per annum and are payable on demand.
	On January 9, 2014, the Company entered into a Securities Purchase Agreement and executed a Convertible Promissory Note with Asher Enterprises in the sum of $32,500. On or about January 29, 2014, the proceeds of the note, net of $2,500 in legal fees, were paid to the Company’s independent accounting firm.
	On January 27, 2014, the Company issued 68,306 shares of common stock upon the conversion of $15,000 in convertible debentures held by Asher Enterprises at a conversion price of $0.2196 per share.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Oct. 31, 2013
Accounting Policies [Abstract]	'
Principles of Consolidation	'
	Principles of Consolidation
	The accompanying consolidated financial statements include the accounts of the Company and its subsidiary, Micro Imaging Technology (“MIT”). As of October 31, 2005, the operations of the Company’s subsidiaries, Electropure EDI, Inc. and Electropure Holdings, LLC, were discontinued and the Company became a development stage company. All significant intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual amounts could differ from those estimates.
Changes in Capitalization and Reverse Stock Split	'
	Changes in Capitalization and Reverse Stock Split
	On February 8, 2013, the Company amended its Articles of Incorporation and decreased the authorized number of shares of Common Stock from 2.5 billion to 25 million shares. At the same time, the Company underwent a five hundred-for-one (500:1) reverse stock split of its Common Stock and Redeemable Convertible Preferred Stock. For purposes of this Annual Report, all issuances of common stock and options or warrants to purchase common stock, if any, are reflected retroactively in post-reverse split amounts. As of October 31, 2013, the reverse split effected by the Company resulted in a reduction in capital stock and an increase in additional paid-in capital in the amount of $24,677,786.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	For purposes of reporting within the statement of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents.
Impairment of Long-Lived Assets	'
	Impairment of Long-Lived Assets
	The Company annually evaluates its long-lived assets, including identifiable intangible assets for potential impairment. When circumstances indicate that the carrying amount of an asset is not recoverable, as demonstrated by the projected undiscounted cash flows, an impairment loss is recognized. The Company’s management has determined that there was no such impairment present at October 31, 2013 and 2012.
Inventory	'
	Inventory
	Inventory is stated at the lower of cost or market. Cost is determined on a first-in, first-out (FIFO) basis. The Company’s management monitors inventory for excess and obsolete items and makes necessary valuation corrections when such adjustments are required.
Property and Equipment	'
	Property and Equipment
	Property and equipment are recorded at cost and are depreciated using the straight-line method over an expected useful life of 3 or 5 years. The leasehold improvements made to the Company’s leased facility are being depreciated over an expected useful life of 5 years. Expenditures for normal maintenance and repairs are charged to operations. The cost and related accumulated depreciation of assets are removed from the accounts upon retirement or other disposition, and the resulting profit or loss is reflected in the Statement of Operations. Renewals and betterments that materially extend the life of the assets are capitalized.
	The production tooling for the Company’s revised MIT 1000 has been capitalized and the $14,000 cost is being amortized over an estimated useful life of 3 years.
Software Costs	'
	Software Costs
	The Company capitalized $35,313 in fiscal 2013 in the development of proprietary software for the MIT 1000 rapid microbial identification system. The cost of the software is being amortized on a straight-line basis over 3 years.
Advertising Costs	'
	Advertising Costs
	The Company charges advertising costs to expense as incurred. The Company incurred $17,123 and $ 25, 357 in advertising expense during the fiscal year ended October 31, 2013 and 2012 respectively.
Accrued Payroll, Payroll Taxes and Benefits	'
	Accrued Payroll, Payroll Taxes and Benefits
	From April 2010 through March 2012, payments made to two employees were recorded as reductions in accrued and unpaid payroll. In April 2012, the Company reclassified such payments as net payroll payments; calculated and recorded the employer and employee taxes that should have been withheld on such payment. Federal and state payroll tax returns have been filed for the last three quarters of 2010, all of 2011 and the first quarter of 2012. The Company recorded a total of $81,206 and $20,560 in federal and state payroll taxes due, respectively. Estimated federal penalties and interest on the late filings and payments, in the sum of $24,196, have been accrued as of October 31, 2013. On September 20, 2012 and May 14, 2013, the Internal Revenue Service filed a Notice of Federal Tax Lien against the Company assessing $58,858 and $13,605, respectively for unpaid taxes, penalties and interest. The Company is in contact with the Internal Revenue Service to work out a payment schedule for the amounts due.
	Estimated state penalties and interest of $4,316 on the above late filings were accrued. A Notice of Tax Lien for a portion of the taxes due was filed by the State of California on November 9, 2012 in the amount of $8,206, including penalty and interest. In October 2013, the California tax authority levied the Company’s account in the sum of $13,807 with an additional levy of $5,451 in November 2013. On December 17, 2013, the Company entered into an installment agreement with the California tax authority to pay $304 per month commencing January 27, 2014 until the remaining balance due has been satisfied.
	Accrued Payroll and Benefits consist of the above payroll taxes, salaries, wages, and vacation benefits earned by employees, but not disbursed as of October 31, 2013 and includes payroll earned, but unpaid to various employees between January 16, 2013 and October 31, 2013. Accrued Payroll also includes the above estimated penalties and interest due on such unpaid payroll taxes. Liability for vacation benefits is accrued when earned monthly and reduced when taken. At the end of each fiscal period, the balance in the accrued vacation benefits liability account is adjusted to reflect current pay rates. Annual leave earned but not taken is considered an unfunded liability since this leave will be funded from future appropriations when it is actually taken by employees.
Concentration of Credit Risk and Other Risks and Uncertainties	'
	Concentration of Credit Risk and Other Risks and Uncertainties
	Accounts Payable – Trade
	As of October 31, 2013, the amount due to a former consultant to the Company, $112,000, represented 33% of the total amount due for accounts payable to non-affiliates. As of October 31, 2013, the Company owed its current independent accounting firm $33,500, which represents 10% of the total amount due for accounts payable. An additional 19% of accounts payable, or $64,952, is due legal counsel in the Alpine MIT Partners litigation in Texas. The Company also owes local counsel $34,749 in accrued fees as of October 31, 2013, which represents 10% of the total amount due for accounts payable.
	Litigation and Claims
	Alpine MIT Partners
	On May 16, 2012, Alpine MIT Partners, LLC (Plaintiffs) filed a civil action against the Company and its Chairman and Chief Executive Officer, Jeffrey G. Nunez, (collectively, the Company), in the Texas District Court, Travis County. Plaintiffs alleged breach of contract and civil conspiracy, as well as tortious interference with contractual relations and prospective business relations. The lawsuit alleges that the Company breached certain provisions of a March 7, 2012 Securities Purchase Agreement the Company executed with the Plaintiff to sell up to $2.0 million of 7% Senior Secured five-year Convertible Debentures convertible into shares of common stock at a conversion rate of $.003 per share. The purchase and sale of the first $1.0 million Debenture was scheduled to close on or before April 6, 2012 and was subject to, among other things, Alpine closing the necessary equity funding to consummate the transactions. No money was ever received by the Company from Alpine. At a March 7, 2013 hearing, the Texas court upheld the Company’s argument and dismissed the complaint against the Company for lack of jurisdiction.
	In August, 2013, Alpine filed an amended Complaint against Jeffrey Nunez in the Texas case alleging tortuous interference and conspiracy to terminate the March 7, 2012 Securities Purchase Agreement. Mr. Nunez believes that the allegations of the lawsuit against him have no merit and intends to vigorously defend the matter.
	On January 10, 2013, the Company learned that Plaintiffs had filed a lien against the Company’s patents on May 8, 2012 with the California Secretary of State under the Uniform Commercial Code. On or about January 29, 2013, the Company filed suit against Alpine MIT Partners, LLC in the Orange County, California Superior Court alleging, among other claims, that the UCC filing is unauthorized. The lawsuit also names the managing director and managing member of Alpine as Defendants and alleges that they made false promises, intentional misrepresentations and breached the contract which is the subject of the Texas suit. The Company is seeking damages of $1.6 million. This lawsuit is currently in the discovery phase.
	Michael W. Brennan
	Concurrent with his April 13, 2012 resignation as Chairman of the Board of Directors and Chief Executive Officer, the Company agreed to repay a total of $160,000 in principal loans, $24,339 in accrued interest and $13,120 in unpaid fees and expenses due Michael Brennan over a 25-month payment schedule commencing May 1, 2012. Due to lack of funds, the Company has not made payments due Mr. Brennan since February 2013, each in the amount of $7,500. As of October 31, 2013, the principal balance due under the agreement amounted to $114,450 and, although Mr. Brennan originally waived interest on the note, the Company has accrued $11,750 in interest on that amount as of October 31, 2013.
	On or about October 4, 2013, Mr. Brennan filed a lawsuit in the California Superior Court of Los Angeles for breach of contract for failure to pay monies due him under the above 2012 agreement. The lawsuit seeks $123,509 in principal damages, plus interest, costs and attorney fees. The Company has filed an answer to the complaint and is contesting the amount due Mr. Brennan. This lawsuit is currently in the discovery phase.
	See also Item 13 – “Subsequent Events.”
	In accordance with accounting standards regarding loss contingencies, the Company accrues an undiscounted liability for those contingencies where the incurrence of a loss is probable and the amount can be reasonably estimated, and the Company discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for its financial statements not to be misleading. The Company does not record liabilities when the likelihood that the liability has been incurred is probable but the amount cannot be reasonably estimated, or when the liability is believed to be only reasonably possible or remote.
	Because litigation outcomes are inherently unpredictable, the Company’s evaluation of legal proceedings often involves a series of complex assessments by management about future events and can rely heavily on estimates and assumptions. If the assessments indicate that loss contingencies that could be material to any one of its financial statements are not probable, but are reasonably possible, or are probable, but cannot be estimated, then the Company discloses the nature of the loss contingencies, together with an estimate of the range of possible loss or a statement that such loss is not reasonably estimable. While the consequences of certain unresolved proceedings are not presently determinable, and an estimate of the probable and reasonably possible loss or range of loss in excess of amounts accrued for such proceedings cannot be reasonably made, an adverse outcome from such proceedings could have a material adverse effect on its financial statements in any given reporting period. However, in the opinion of Management, after consulting with legal counsel, the ultimate liability related to the current outstanding litigation is not expected to have a material adverse effect on its financial statements.
	Management is of the opinion that the ultimate resolution of such matters now pending will not have a material adverse effect on the Company’s consolidated results of operations, financial position or cash flows. However, the outcome of legal proceedings cannot be predicted with any degree of certainty.
Antidilution Liability	'
	Antidilution Liability
	The Company has recorded a $23,358 liability to allow for the possible dilutive impact of equity issuances that alter or effect conversion or exchange rates existing on the various dates of conversion or exercise of securities having adjustable conversion rates. The liability is adjusted to reflect current fair market value at the end of each fiscal period. Due to decline in the Company;s stock price, we recorded a gain of $42,043 at October 31, 2013.
Research and Development	'
	Research and Development
	Research and development expenditures are charged to expense as they are incurred. The Company’s research and development activities include ongoing work on various uses of the micro imaging multi-angle laser light scattering technology. Contract research and development expenditures are expensed as incurred.
Stock Based Compensation	'
	Stock Based Compensation
	The Company measures share based compensation at the grant date, based on the fair value of the award using the Black-Scholes Option Pricing Model, and recognizes such compensation as an expense over the employee’s requisite service period (generally the vesting period of the equity grant).
	The Company recognized no share-based compensation expense during the fiscal years ended October 31, 2013 and 2012.
	Activity under the Company’s stock option plans is included in Note 9.
Income Taxes	'
	Income Taxes
	The Company accounts for income taxes under the liability method. Under the liability method, deferred income taxes are determined based on differences between the financial reporting and tax bases of assets and liabilities. They are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company is required to adjust its deferred tax liabilities in the period when tax rates or the provisions of the income tax laws change. Valuation allowances are established to reduce deferred tax assets to the amounts expected to be realized.
	The Company has not yet completed its state and federal corporate income tax returns for the fiscal year ended October 31, 2012, which were due to be filed (with an extension), by July 15, 2013. Neither has the Company paid the $1,600 state income tax due for fiscal 2012 or the estimated tax of $1,600 due to the state for the fiscal year ended October 31, 2013. The Company has accrued $1,150 as of October 31, 2013 as penalties and interest related to these late payments and filings.
Loss Per Share	'
	Loss Per Share
	Basic earnings (loss) per share excludes dilution and is calculated by dividing income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that then share in the earnings (loss) of the entity. Common stock equivalents of 872,363 and 254,877 as of October 31, 2013 and 2012, respectively, have been omitted from the earnings (loss) per share calculation, as their effect would be antidilutive.
New Accounting Pronouncements	'
	New Accounting Pronouncements
	On January 31, 2013, the FASB issued Accounting Standards Update [ASU] 2013-01, entitled Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities. The guidance in ASU 2013-01 amends the requirements in the FASB Accounting Standards Codification [FASB ASC] Topic 210, entitled Balance Sheet. The ASU 2013-01 amendments to FASB ASC 210 clarify that ordinary trade receivables and receivables in general are not within the scope of ASU 2011-11, entitled Disclosure about Offsetting Assets and Liabilities, where that ASU amended the guidance in FASB ASC 210. As those disclosures now are modified with the ASU 2013-01 amendments, the FASB ASC 210 balance sheet offsetting disclosures now clearly are applicable only where reporting entities are involved with bifurcated embedded derivatives, repurchase agreements, reverse repurchase agreements, and securities borrowing and lending transactions that either are offset using the FASB ASC 210 or 815 requirements, or that are subject to enforceable master netting arrangements or similar agreements. ASU 2013-01 is effective for annual reporting periods beginning on or after January 1, 2013, and interim periods within those annual periods. The adoption of this ASU is not expected to have a material impact on our financial statements.
	On February 28, 2013, the FASB issued Accounting Standards Update [ASU] 2013-04, entitled Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date. The ASU 2013-04 amendments add to the guidance in FASB Accounting Standards Codification [FASB ASC] Topic 405, entitled Liabilities and require reporting entities to measure obligations resulting from certain joint and several liability arrangements where the total amount of the obligation is fixed as of the reporting date, as the sum of the following:
		●	The amount the reporting entity agreed to pay on the basis of its arrangement among co-obligors.
		●	Any additional amounts the reporting entity expects to pay on behalf of its co-obligors.
	While early adoption of the amended guidance is permitted, for public companies, the guidance is required to be implemented in fiscal years, and interim periods within those years, beginning after December 15, 2013. The amendments need to be implemented retrospectively to all prior periods presented for obligations resulting from joint and several liability arrangements that exist at the beginning of the year of adoption. The adoption of ASU 2013-04 is not expected to have a material effect on the Company’s operating results or financial position.
	On April 22, 2013, the FASB issued Accounting Standards Update [ASU] 2013-07, entitled Liquidation Basis of Accounting. With ASU 2013-07, the FASB amends the guidance in the FASB Accounting Standards Codification [FASB ASC] Topic 205, entitled Presentation of Financial Statements. The amendments serve to clarify when and how reporting entities should apply the liquidation basis of accounting. The guidance is applicable to all reporting entities, whether they are public or private companies or not-for-profit entities. The guidance also provides principles for the recognition of assets and liabilities and disclosures, as well as related financial statement presentation requirements. The requirements in ASU 2013-07 are effective for annual reporting periods beginning after December 15, 2013, and interim reporting periods within those annual periods. Reporting entities are required to apply the requirements in ASU 2013-07 prospectively from the day that liquidation becomes imminent. Early adoption is permitted. The adoption of ASU 2013-07 is not expected to have a material effect on the Company’s operating results or financial position.
	On July 18, 2013, the FASB issued ASU 2013-11, which provides guidance on financial statement presentation of an unrecognized tax benefit2 when a net operating loss (NOL) carryforward, a similar tax loss, or a tax credit carryforward exists. The FASB’s objective in issuing this ASU is to eliminate diversity in practice resulting from a lack of guidance on this topic in current U.S. GAAP. This ASU applies to all entities with unrecognized tax benefits that also have tax loss or tax credit carryforwards in the same tax jurisdiction as of the reporting date. Under the ASU, an entity must present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, in the financial statements as a reduction to a deferred tax asset for an NOL carryforward, a similar tax loss, or a tax credit carryforward except when:
		●	An NOL carryforward, a similar tax loss, or a tax credit carryforward is not available as of the reporting date under the governing tax law to settle taxes that would result from the disallowance of the tax position.
		●	The entity does not intend to use the deferred tax asset for this purpose (provided that the tax law permits a choice).
	If either of these conditions exists, an entity should present an unrecognized tax benefit in the financial statements as a liability and should not net the unrecognized tax benefit with a deferred tax asset.
	ASU 2013-11 is effective for public entities for fiscal years beginning after December 15, 2013, and interim periods within those years. The adoption of ASU 2013-11 is not expected to have a material effect on the Company’s operating results or financial position.
	There were various other updates recently issued, many of which represented technical corrections to the accounting literature or application to specific industries. N one of the updates are expected to a have a material impact on our consolidated financial position, results of operations or cash flows.

Property_Plant_and_Equipment_T

Property, Plant and Equipment (Tables)	12 Months Ended
	Oct. 31, 2013
Property, Plant and Equipment [Abstract]	'
Schedule of Property Plant and Equipment	'
	At October 31, property, plant and equipment consisted of the following:
		2013			2012
	Machinery and equipment	$	235,504		$	229,100
	Furniture and fixtures		74,326			74,326
	Leasehold improvements		77,779			77,779
	Production molding		14,000			14,000
	Software		35,313			-
			436,922			395,205
	Less: accumulated depreciation		(325,352	)		(272,164	)
	Total property and equipment, net	$	111,570		$	123,041

Convertible_Debentures_Tables

Convertible Debentures (Tables)	12 Months Ended
	Oct. 31, 2013
Convertible Notes Payable [Abstract]	'
Schedule of Fair Value of Financial Instruments Liabilities	'
	The following table sets forth, by level within the fair value hierarchy, our financial instrument liabilities as of October 31, 2013 (See also Note 6 – Convertible Debentures – “Series 1 Notes”):
		Quoted			Significant		Significant		Total
		Prices in			Other		Unobservable
		Active Markets For Identical Assets			Observable		Inputs
					Inputs
		(Level 3)			(Level 3)		(Level 3)
	Derivative liability	$	—		$	—	$	75,557	$	75,557
	Total	$	—		$	—	$	75,557	$	75,557
Summary of Changes in Fair Value of Level 3 Financial Instrument Liability	'
	The following table sets forth a summary of changes in the fair value of our Level 3 financial instrument liability for the fiscal years ended October 31, 2012 and 2013:
		Fair Value
		Measurements
		Using
		Significant
		Unobservable
		Inputs
		(Level 3)
	Balance October 31, 2012	$	-
	Additions		84,310
	Net gain included in earnings		(8,753	)
	Settlements		-
	Balance October 31, 2013	$	75,557
Summary of Convertible Debentures and Series 1 Notes	'
	At October 31, 2013 and 2012, without taking into effect any unamortized discounts, convertible debentures and Series 1 notes consisted of the following:
		2013			2012
	Series 1 Notes, principal and interest at 8% maturing through May 25, 2012.	$	85,000		$	—
	Convertible note payable to stockholder; principal and interest at 10% due on May 31, 2012.	$	64,868		$	64,868
	Convertible notes payable to various stockholders; principal and interest at 6% due on August 1, 2012 and December 31, 2012.	$	—		$	12,500
			149,868			77,368
	Less current maturities	$	149,868		$	77,368
	Long term portion of Convertible and Series 1 notes payable	$	—		$	—
Schedule of Remaining Outstanding Notes Maturity	'
	Of the above notes, $64,868 is currently due and payable. The Company’s outstanding notes mature as follows for the years ending October 31:
	2014		$	85,000
	Thereafter			—
			$	85,000

Notes_Payable_to_an_Officer_an1

Notes Payable to an Officer and Stockholder (Tables)	12 Months Ended
	Oct. 31, 2013
Schedule of Maturities of Notes Payable	'
	Of the above notes, $64,868 is currently due and payable. The Company’s outstanding notes mature as follows for the years ending October 31:
	2014		$	85,000
	Thereafter			—
			$	85,000
Officer And Stockholders [Member]	'
Schedule of Unamortized Discounts, Notes Payable to Officers and Stockholders	'
	At October 31, 2012 and 2011, without taking into effect any unamortized discounts, notes payable to an officer and to stockholders consisted of the following:
		2013			2012
	Unsecured, interest-free convertible notes payable to former officer/director of the Company; principal due on payment schedule through May 2014.	$	113,450		$	136,950
	Unsecured notes payable to officers/directors of the Company; principal and interest at 6% due on demand.	$	36,000		$	—
	Unsecured convertible note payable to various stockholders; principal and interest at 6% due between December 9, 2010 and March 31, 2013.	$	52,000		$	52,000
			201,450			188,950
	Less current maturities	$	201,450		$	142,844
	Long term portion of notes payable	$	—		$	46,106
Schedule of Maturities of Notes Payable	'
	The Company’s outstanding notes mature as follows for the years ending:
	2014		$	201,450
	Thereafter			—
			$	201,450

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Oct. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Components of Income Tax Expense	'
	At October 31, the components of the income tax expense are as follows:
		2013			2012
	Current tax expense:
	Federal	$	—		$	—
	State		1,600			1,600
	Total corporate tax expense		1,600			1,600
	Deferred tax expenses:
	Federal		—			—
	State		—			—
			—			—
	Total provision:	$	1,600		$	1,600
Schedule of Net Deferred Tax Assets and Liabilities During Period	'
	Significant components of the Company’s net deferred income tax assets/ (liabilities) at October 31, 2013 were as follows:
	Current deferred tax assets:
	Accrued vacation	$	—
	Book compensation for options and warrants		—
	Other		—
	Total current deferred tax assets		—
	Valuation allowance		—
	Net deferred current tax assets	$	—
	Noncurrent deferred tax assets:
	Net operating loss carryforward	$	10,782,000
	Other credit carryforward		165,000
	Depreciation and amortization		—
	Total noncurrent deferred tax assets		10,947,000
	Valuation allowance		(10,947,000	)
	Net deferred noncurrent tax assets		—
	Total deferred tax assets	$	—
Schedule of Effective Income Tax Rate Reconciliation of U.S Statutory Income Tax Rate	'
	Reconciliation of the effective income tax rate to the U.S. statutory income tax rate is as follows:
		2013			2012
	Tax expense at U.S. statutory income tax rate		(34.0	)%		(34.0	)%
	State tax		(5.8	)%		(5.8	)%
	Utilization of net operating loss		0	%		0	%
	Change in beginning balance of valuation allowance		39.8	%		39.8	%
	Effective income tax rate		—	%		—	%

Stock_Options_and_Warrants_Tab

Stock Options and Warrants (Tables)	12 Months Ended
	Oct. 31, 2013
Stock Options And Warrants	'
Summary of Stock Options Granted	'
	The options granted have contractual lives ranging from three to ten years.
				Number of				Weighted			Weighted			Aggregate
				Options				Average			Average			Intrinsic
								Exercise			Remaining			Value
								Price			Contractual
											Term
											(in years)
	Outstanding at October 31, 2011				6,000			$	45			2.1		$	—
	Granted				—				—
	Exercised				—				—
	Expired				(400	)			80
	Canceled				—				—
	Outstanding at October 31, 2012				5,600				40			1.2		$	—
	Granted				—				—
	Exercised				—				—
	Expired				(1,200	)			145.83
	Canceled				—				—
	Outstanding at October 31, 2013				4,400			$	13.35			0.4		$	—
weighted Average Assumptions for Grants	'
	The values of the options were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions for grants made in 2013 and 2012.
				2013				2012
	Risk-free interest rate			—				—	%
	Expected dividend yield			—				—
	Expected stock price volatility			—				—
	Expected life in years			—				—
Summary of Options Outstanding	'
	Summary information about the Company’s options outstanding at October 31, 2013 is set forth in the table below. Options outstanding at October 31, 2013 expire between February 2014 and January 2016.
	Range of				Options				Weighted			Weighted			Options			Weighted
	Exercise				Outstanding				Average			Average			Exercisable			Average
	Prices				October 31, 2013				Remaining			Exercise Price			October 31, 2013			Exercise
									Contractual Life									Price
	$	7.69				4,000				0.3		$	7.69			4,000		$	7.69
	$	70				400				2.2		$	70			400		$	70
	TOTAL:					4,400										4,400
Summary of Warrants Granted to Non-Employees	'
	The following table summarizes the information relating to warrants granted to non-employees as of October 31, 2013 and 2012 and changes during the years then ended. Warrants outstanding at October 31, 2013 expire between February 2014 and June 2016.
				Number of				Weighted
				Warrants				Average
								Exercise
								Price
	Outstanding at October 31, 2011				10,000			$	5
	Granted				413,334				1
	Exercised				—				—
	Cancelled				(266,667	)			1.5
	Expired				(10,000	)			5
	Outstanding at October 31, 2012				146,667				1
	Granted				200,000				0.88
	Exercised				(40,000	)			1
	Cancelled				(66,667	)			1.5
	Expired				—				—
	Outstanding at October 31, 2013				240,000			$	0.9
Weighted Average Assumptions for Grants, Warrants	'
	The values of the warrants were estimated using the Black-Scholes Option Pricing Model with the following weighted average assumptions for grants made in 2013 and 2012:
			2013				2012
	Risk-free interest rate			0.71	%			0.72	%
	Expected dividend yield			—				—
	Expected stock price volatility			1.42				1.89
	Expected life in years			2.0 years				1.7 years
Summary of Warrants Outstanding	'
	Summary information about the Company’s warrants outstanding at October 31, 2013 is as follows:
	Range of			Warrants				Weighted			Weighted			Warrants			Weighted
	Exercise			October 31, 2013				Average			Average			Exercisable			Average
	Prices							Remaining			Exercise			October 31, 2013			Exercise
								Contractual			Price						Price
								Life
	$0.50				50,000				2.6		$	0.5			50,000		$	0.5
	$1.00				190,000				1.8		$	1			190,000		$	1
	TOTAL:				240,000										240,000

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Oct. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Future Minimum Facilities Lease Payments	'
	Future minimum facilities lease payments as of October 31, 2013 are as follows:
	2014	$	19,475
	2015	$	—

Description_of_Business_and_De1

Description of Business and Development Stage Company (Details Narrative)	Oct. 31, 2013
Accounting Policies [Abstract]	'
Percentage of interest owned by the company	81.00%

Basis_of_Presentation_Details_

Basis of Presentation (Details Narrative) (USD $)	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012
Basis Of Presentation	'	'
Net loss	$998,350	$1,249,491
Accumulated deficit	$46,409,831	'

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details Narrative) (USD $)

0 Months Ended

12 Months Ended

24 Months Ended

96 Months Ended

0 Months Ended

12 Months Ended

12 Months Ended

14-May-13

Nov. 09, 2012

Sep. 20, 2012

Apr. 06, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2012

Mar. 31, 2012

Oct. 31, 2013

16-May-12

Oct. 04, 2013

Dec. 31, 2013

Feb. 01, 2013

Apr. 12, 2012

Oct. 31, 2013

Oct. 31, 2013

Feb. 08, 2013

Sep. 14, 2012

Oct. 31, 2013

Feb. 08, 2014

Sep. 14, 2012

Michael W. Brennan [Member]

Michael W. Brennan [Member]

Michael W. Brennan [Member]

Michael W. Brennan [Member]

Leasehold Improvements [Member]

Minimum [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Maximum [Member]

Decrease number of common shares

'

'

'

'

25,000,000

25,000,000

25,000,000

'

25,000,000

'

'

'

'

'

'

'

25,000,000

'

'

250,000,000

'

Reverse stock split

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

five hundred-for-one (500:1) reverse stock split of its Common Stock and Redeemable Convertible Preferred Stock

Increase in additional paid-in capital due to stock split

'

'

'

'

$24,677,786

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Property and equipment expected useful life

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'3 years

'

'

'5 years

'

'

Amortization of property and equipment during estimated useful life

'

'

'

'

14,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amortization of computer equipment

'

'

'

'

35,313

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Advertising expense

'

'

'

'

17,123

25,357

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Federal payroll tax

'

'

'

'

'

'

'

81,206

'

'

'

'

'

'

'

'

'

'

'

'

'

State payroll tax

'

'

'

'

1,600

'

1,600

20,560

'

'

'

'

'

'

'

'

'

'

'

'

'

Estimated penalties and interest on late filings and payments

'

'

'

'

24,196

'

'

'

24,196

'

'

'

'

'

'

'

'

'

'

'

'

Unpaid taxes, penalties and interest

13,605

'

58,858

'

4,316

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Portion of tax filed by State of California

'

8,206

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Notification of levy charges

'

'

'

'

13,807

'

'

'

13,807

'

'

'

'

'

'

'

'

'

'

'

'

Additional Notification of levy charges

'

'

'

'

5,451

'

'

'

5,451

'

'

'

'

'

'

'

'

'

'

'

'

Payments of agreement amount

'

'

'

'

304

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amount due to former consultant

'

'

'

'

112,000

'

'

'

112,000

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of amount due for accounts payable to non-affiliates

'

'

'

'

33.00%

'

'

'

33.00%

'

'

'

'

'

'

'

'

'

'

'

'

Company owes its current independent accouting firm

'

'

'

'

33,500

'

'

'

33,500

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of accounts payable

'

'

'

'

10.00%

'

'

'

10.00%

'

'

'

'

'

'

'

'

'

'

'

'

Outstanding Litigation Fees Payable

'

'

'

'

64,952

'

'

'

64,952

'

'

'

'

'

'

'

'

'

'

'

'

Accrued fees

'

'

'

'

34,749

'

'

'

34,749

'

'

'

'

'

'

'

'

'

'

'

'

Senior secure convertible debentures

'

'

'

'

149,868

77,368

77,368

'

149,868

2,000,000

'

'

'

'

'

'

'

'

'

'

'

Percentage of seior secured convertible debentures

'

'

'

'

'

'

'

'

'

7.00%

'

'

'

'

'

'

'

'

'

'

'

conversion rate

'

'

'

'

'

'

'

'

'

$0.00

'

'

'

'

'

'

'

$0.20

'

'

$1.95

Purchase and sale of debenture

'

'

'

1,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Damages seeking from plaintiff

'

'

'

'

1,600,000

'

'

'

1,600,000

'

'

'

'

'

'

'

'

'

'

'

'

Agreed to repay principle loans

'

'

'

'

'

'

'

'

'

'

'

114,450

7,500

160,000

'

'

'

'

'

'

'

Accrued interest

'

'

'

'

'

'

'

'

'

'

'

11,750

'

24,339

'

'

'

'

'

'

'

Unpaid fees and expenses

'

'

'

'

'

'

'

'

'

'

'

'

'

13,120

'

'

'

'

'

'

'

Law suit seeks principal damages, plus interest

'

'

'

'

'

'

'

'

'

'

123,509

'

'

'

'

'

'

'

'

'

'

Anti-dilution liability

'

'

'

'

23,358

65,401

65,401

'

23,358

'

'

'

'

'

'

'

'

'

'

'

'

Gain on decline of stock price

'

'

'

'

42,043

'

'

'

42,043

'

'

'

'

'

'

'

'

'

'

'

'

Accrued tax amount

'

'

'

'

$1,150

'

'

'

$1,150

'

'

'

'

'

'

'

'

'

'

'

'

Antidilutive common stock equivalents shares excluded from computation of earnings or loss per share

'

'

'

'

872,363

254,877

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Property_Plant_and_Equipment_D

Property, Plant and Equipment (Details Narrative) (USD $)	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012
Property, Plant and Equipment [Abstract]	'	'
Depreciation and amortization expenses	$53,188	$35,925

Property_Plant_and_Equipment_S

Property, Plant and Equipment - Schedule of Property Plant and Equipment (Details) (USD $)

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Dec. 31, 2012

Machinery And Equipment [Member]

Machinery And Equipment [Member]

Furniture And Fixtures [Member]

Furniture And Fixtures [Member]

Leasehold Improvements [Member]

Leasehold Improvements [Member]

Production Molding [Member]

Production Molding [Member]

Software [Member]

Software [Member]

Property and equipment, gross

$436,922

$395,205

$235,504

$229,100

$74,326

$74,326

$77,779

$77,779

$14,000

$14,000

$35,313

'

Less: accumulated depreciation

-325,352

-272,164

'

'

'

'

'

'

'

'

'

'

Total property and equipment, net

$111,570

$123,041

'

'

'

'

'

'

'

'

'

'

Convertible_Debentures_Details

Convertible Debentures (Details Narrative) (USD $)

0 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Jul. 18, 2013

Sep. 14, 2012

Nov. 10, 2010

Oct. 31, 2013

Oct. 31, 2012

16-May-12

Feb. 21, 2012

Oct. 31, 2013

Jun. 15, 2013

Sep. 30, 2011

Nov. 27, 2009

Oct. 31, 2013

Oct. 31, 2013

Sep. 14, 2012

Sep. 14, 2012

Unaffiliated Lender [Member]

Unaffiliated Lender [Member]

Unaffiliated Lender [Member]

Unaffiliated Lender [Member]

Series I Notes [Member]

Other Convertible Notes [Member]

Minimum [Member]

Maximum [Member]

Borrowed from related parties

'

'

$64,868

$64,868

'

'

'

'

'

'

$25,000

'

'

'

'

Aggregate principal amount of convertible notes

'

'

'

'

'

'

387,500

'

12,500

12,500

'

'

'

'

'

Percentage of convertible notes interest rate

'

'

10.00%

'

'

'

8.00%

'

'

6.00%

'

'

'

'

'

Principal amount of debt

42,500

387,500

'

'

'

'

'

'

'

12,500

'

'

'

'

'

Principal amount of outstanding notes increased

'

45,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Principal penalties

'

15,500

'

'

'

'

'

'

'

'

'

'

'

'

'

Shares of common stock on conversion

'

663,219

'

'

'

'

'

'

23,998

17,084

'

'

'

'

'

Conversion price per share

'

'

'

'

'

$0.00

'

'

$0.57

'

'

'

'

$0.20

$1.95

Payment for legal expenses

5,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of stock reserve by transfer agent

'

'

'

'

'

'

'

'

'

'

'

1,400,000

'

'

'

Aggregate shares of common stock

'

'

'

'

315,500

'

'

'

'

'

'

348,360

279,603

'

'

Value exceeds the principal balance

'

'

'

'

'

'

'

'

'

'

'

89,180

74,934

'

'

Percentage of discount on price of common stock

39.00%

'

42.00%

'

'

'

'

'

'

'

'

'

'

'

'

Derivative liabilities

'

'

'

75,557

'

'

'

'

'

'

'

'

'

'

'

Exercise price of share

'

'

'

'

'

'

'

'

'

'

'

$0.31

'

'

'

Common share price

'

'

'

'

'

'

'

'

'

'

'

$0.50

'

'

'

Discount rate

'

'

'

'

'

'

'

'

'

'

'

8.00%

'

'

'

Volatility rate

'

'

'

'

'

'

'

'

'

'

'

138.00%

'

'

'

Intrinsic value of conversion feature

'

'

'

46,973

'

'

'

10,507

'

'

'

'

'

'

'

Accrued interest

'

'

'

19,300

'

'

'

'

1,299

2,876

'

'

'

'

'

Maturity date of debt

22-Apr-14

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Other expenses relating to debt

'

'

'

'

'

'

'

$3,202

'

'

'

'

'

'

'

Convertible_Debentures_Schedul

Convertible Debentures - Schedule of Fair Value of Financial Instruments Liabilities (Details) (USD $)	Oct. 31, 2013	Oct. 31, 2012
Derivative liability	$75,557	'
Total	201,450	142,000
Quoted Prices in Active Markets For Identical Assets (Level 3) [Member]	'	'
Derivative liability	'	'
Total	'	'
Significant Other Observable Inputs (Level 3) [Member]	'	'
Derivative liability	'	'
Total	'	'
Fair Value Measurements Using Significant Unobservable Inputs (Level 3) [Member]	'	'
Derivative liability	75,557	'
Total	$75,557	'

Convertible_Debentures_Summary

Convertible Debentures - Summary of Changes in Fair Value of Level 3 Financial Instrument Liability (Details) (Fair Value Measurements Using Significant Unobservable Inputs (Level 3) [Member], USD $)	12 Months Ended
	Oct. 31, 2013
Fair Value Measurements Using Significant Unobservable Inputs (Level 3) [Member]	'
Balance October 31, 2012	'
Additions	84,310
Net gain included in earnings	-8,753
Settlements	'
Balance July 31, 2013	$75,557

Convertible_Debentures_Schedul1

Convertible Debentures - Schedule of Convertible Debentures (Details) (USD $)	Oct. 31, 2013	Oct. 31, 2012	16-May-12
Convertible notes payable	$149,868	$77,368	'
Less current maturities	149,868	77,368	2,000,000
Long term portion of Convertible and Series 1 notes payable	'	'	'
Series 1 Note, Principal and Interest at 8% Maturing on May 25, 2012 [Member]	'	'	'
Convertible notes payable	85,000	'	'
Convertible Note Payable at 10% Due on May 31, 2012 [Member]	'	'	'
Convertible notes payable	64,868	64,868	'
Convertible Notes Payable at 6% Maturing on August 1, 2012 and December 31, 2012 [Member]	'	'	'
Convertible notes payable	'	$12,500	'

Convertible_Debentures_Schedul2

Convertible Debentures - Schedule of Convertible Debentures (Details) (Parenthetical)

0 Months Ended

12 Months Ended

12 Months Ended

Jul. 18, 2013

Feb. 21, 2012

Nov. 10, 2010

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 31, 2012

Series 1 Note, Principal and Interest at 8% Maturing on May 25, 2012 [Member]

Series 1 Note, Principal and Interest at 8% Maturing on May 25, 2012 [Member]

Convertible Note Payable at 10% Due on May 31, 2012 [Member]

Convertible Note Payable at 10% Due on May 31, 2012 [Member]

Convertible Notes Payable at 6% Maturing on August 1, 2012 and December 31, 2012 [Member]

Convertible Notes Payable at 6% Maturing on August 1, 2012 and December 31, 2012 [Member]

Series 1 Note, Principal and Interest at 8% Maturing on May 25, 2012 [Member]

Series 1 Note, Principal and Interest at 8% Maturing on May 25, 2012 [Member]

Convertible Notes Payable at 6% Maturing on December 31, 2012 [Member]

Convertible Notes Payable at 6% Maturing on December 31, 2012 [Member]

Convertible notes payable, interest rate

'

8.00%

10.00%

8.00%

8.00%

10.00%

10.00%

6.00%

6.00%

'

'

'

'

Convertible notes payable, maturity date

22-Apr-14

'

'

'

'

31-May-12

31-May-12

'

'

25-May-14

25-May-14

1-Aug-12

31-Dec-12

Convertible_Debentures_Schedul3

Convertible Debentures - Schedule of Remaining Outstanding Notes Maturity (Details) (USD $)	Oct. 31, 2013
Convertible Notes Payable [Abstract]	'
2014	$85,000
Thereafter	'
Total	$85,000

Notes_Payable_to_an_Officer_an2

Notes Payable to an Officer and Stockholder (Details Narrative) (USD $)	Oct. 31, 2013	Oct. 31, 2012
Notes payable gross	$201,450	$188,950
Officer And Director [Member]	'	'
Notes payable gross	113,450	'
Various Stockholders [Member]	'	'
Notes payable gross	$52,000	'

Notes_Payable_to_an_Officer_an3

Notes Payable to an Officer and Stockholder - Schedule of Unamortized Discounts, Notes Payable to Officers and Stockholders (Details) (USD $)	Oct. 31, 2013	Oct. 31, 2012
Notes payable gross	$201,450	$188,950
Less current maturities	201,450	142,000
Long term portion of notes payable	'	46,106
Unsecured, Interest-Free Convertible Notes Payable To Former Officer/Director Of The Company; Principal Due On Payment Schedule Through May 2014 [Member]	'	'
Notes payable gross	113,450	136,950
Unsecured Notes Payable To Officers/Directors Of The Company; Principal Nad Interest At 6% Due On Demand [Member]	'	'
Notes payable gross	36,000	'
Unsecured Convertible Note Payable To Various Stockholders; Principal And Interest At 6% Due Between December 9, 2010 And March 31, 2011 [Member]	'	'
Notes payable gross	$52,000	$52,000

Notes_Payable_to_an_Officer_an4

Notes Payable to an Officer and Stockholder - Schedule of Unamortized Discounts, Notes Payable to Officers and Stockholders (Details) (Parenthetical)	0 Months Ended			12 Months Ended
	Jul. 18, 2013	Feb. 21, 2012	Nov. 10, 2010	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2013	Oct. 31, 2012
				Unsecured, Interest-Free Convertible Notes Payable To Former Officer/Director Of The Company; Principal Due On Payment Schedule Through May 2014 [Member]	Unsecured, Interest-Free Convertible Notes Payable To Former Officer/Director Of The Company; Principal Due On Payment Schedule Through May 2014 [Member]	Unsecured Notes Payable To Officers/Directors Of The Company; Principal Nad Interest At 6% Due On Demand [Member]	Unsecured Notes Payable To Officers/Directors Of The Company; Principal Nad Interest At 6% Due On Demand [Member]	Unsecured Convertible Note Payable To Various Stockholders; Principal And Interest At 6% Due Between December 9, 2010 And March 31, 2011 [Member]	Unsecured Convertible Note Payable To Various Stockholders; Principal And Interest At 6% Due Between December 9, 2010 And March 31, 2011 [Member]
Maturity date	22-Apr-14	'	'	31-May-14	31-May-14	'	'	'	'
Debt instrument interest rate	'	8.00%	10.00%	'	'	6.00%	6.00%	6.00%	6.00%

Notes_Payable_to_an_Officer_an5

Notes Payable to an Officer and Stockholder - Schedule of Maturities of Notes Payable (Details) (USD $)	Oct. 31, 2013	Oct. 31, 2012
Debt Disclosure [Abstract]	'	'
2014	$201,450	'
Thereafter	'	'
Total	$201,450	$188,950

Income_Taxes_Details_Narrative

Income Taxes (Details Narrative) (USD $)	12 Months Ended
	Oct. 31, 2013
Income Tax Disclosure [Abstract]	'
Change in total valuation allowance	$396,000
Federal net operating loss carryforwards	27,091,000
State net operating loss carryforwards	21,561,000
Operating loss carryforwards expiration date	'through 2013 and 2023
Federal tax credit carryforwards	165,000
State research and development tax credit carryforwards	$130,000
Recognized benefit cumulatively greater than recognized percentage	50.00%

Schedule_of_Components_of_Inco

Schedule of Components of Income Tax Expense (Details) (USD $)	12 Months Ended		24 Months Ended	96 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Mar. 31, 2012	Oct. 31, 2013
Income Tax Disclosure [Abstract]	'	'	'	'
Federal	'	'	'	'
State	1,600	1,600	20,560	'
Total corporate tax expense	1,600	1,600	'	'
Federal	'	'	'	'
State	'	'	'	'
Deferred tax expense, total	'	'	'	'
Total provision	$1,600	$1,600	'	$12,800

Schedule_of_Net_Deferred_Tax_A

Schedule of Net Deferred Tax Assets and Liabilities During Period (Details) (USD $)	Oct. 31, 2013
Income Tax Disclosure [Abstract]	'
Current deferred tax assets, Accrued vacation	'
Current deferred tax assets, Book compensation for options and warrants	'
Current deferred tax assets, Other	'
Total current deferred tax assets	'
Current deferred tax assets, Valuation allowance	'
Net deferred current tax assets	'
Noncurrent deferred tax assets, Net operating loss carryforward	10,782,000
Noncurrent deferred tax assets, Other credit carryforward	165,000
Noncurrent deferred tax assets, Depreciation and amortization	'
Total noncurrent deferred tax assets	10,947,000
Noncurrent deferred tax assets, Valuation allowance	-10,947,000
Net deferred noncurrent tax assets	'
Total deferred tax assets	'

Schedule_of_Effective_Income_T

Schedule of Effective Income Tax Rate Reconciliation of U.S Statutory Income Tax Rate (Details)	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012
Income Tax Disclosure [Abstract]	'	'
Tax expense at U.S. statutory income tax rate	-34.00%	-34.00%
State tax	-5.80%	-5.80%
Utilization of net operating loss	0.00%	0.00%
Change in beginning balance of valuation allowance	39.80%	39.80%
Effective income tax rate	'	'

Stockholders_Deficit_Details_N

Stockholders' Deficit (Details Narrative) (USD $)

0 Months Ended

1 Months Ended

12 Months Ended

96 Months Ended

1 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

Aug. 13, 2013

Aug. 07, 2013

Jun. 28, 2013

Jun. 15, 2013

Feb. 22, 2013

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Jan. 31, 2001

Jan. 31, 2001

Oct. 17, 2013

Aug. 13, 2013

Aug. 07, 2013

Nov. 29, 2012

Aug. 13, 2013

Oct. 17, 2013

3-May-13

Jan. 11, 2013

Oct. 17, 2013

Jan. 11, 2013

Apr. 26, 2013

Apr. 26, 2013

Jun. 04, 2013

Jun. 04, 2013

Jun. 04, 2013

Sep. 05, 2013

Series C Preferred Stock [Member]

Series D Preferred Stock [Member]

Warrant [Member]

Warrant [Member]

Warrant [Member]

Gregg Newhuis [Member]

Major Stockholder [Member]

Major Stockholder [Member]

Major Stockholder [Member]

Major Stockholder [Member]

Major Stockholder [Member]

Victor Hollander [Member]

Jeffrey Nunez [Member]

Jeffrey Nunez [Member]

Major Shareholder [Member]

Major Shareholder [Member]

Major Stockholder [Member]

Unaffiliated Investor [Member]

Warrant [Member]

Warrant [Member]

Warrant [Member]

Warrant [Member]

Common stock issued during period, shares

'

'

13,333

'

'

'

'

'

'

'

'

'

'

200,000

60,000

40,000

211,764

'

'

3,333

435

196

50,000

'

'

20,000

Common stock issued during period

$30,000

$10,000

$10,000

'

'

'

'

'

'

'

$10,000

'

'

$100,000

$30,000

$20,000

$180,000

'

'

$5,000

'

'

$25,000

'

'

$10,000

Common stock price per share

$0.50

$0.50

$0.75

'

'

'

'

'

'

'

$1

$1

$1

$0.50

$0.50

$0.50

$0.85

$1

$1

$1.50

$1.63

$1.45

$0.50

$0.50

$1

$0.50

Warrant issued to purchase number of common stock, shares

'

'

'

'

'

'

'

'

'

'

10,000

30,000

10,000

'

'

'

'

40,000

20,000

'

'

'

'

50,000

100,000

'

Warrant issued to purchase number of common stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

40,000

20,000

'

'

'

'

'

'

'

Common shares issued for services, shares

'

'

'

'

16,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common shares issued for services

'

'

'

'

20,000

993

132,796

3,212,484

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of transaction fee received

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5.00%

5.00%

'

'

'

'

Value of loan converted into common stock

'

'

'

12,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Value of accrued interest converted into common stock

'

'

'

$1,299

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of converted common stock, shares

'

'

'

0.575

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Converted common stock, per share

'

'

'

$23,998

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Redeemable preferred stock price per share

'

'

'

'

'

$0.01

'

$0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt ratio as per California law

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

(a) the amount of the proposed distribution, and (b) 1.25 times its liabilities, excluding deferred taxes, deferred income, and deferred credits

Preferred stock, par value

'

'

'

'

'

$1

'

$1

$250,000

$500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, shares authorized

'

'

'

'

'

1,000,000

'

1,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock convertable into common stock at holder option

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

convertible at the option of the holder into four (4) shares of common stock

convertible into two (2) shares of common stock

Liquidation preference per share

'

'

'

'

'

$0.01

'

$0.01

$4

$2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock_Options_and_Warrants_Det

Stock Options and Warrants (Details Narrative) (USD $)

0 Months Ended

1 Months Ended

12 Months Ended

96 Months Ended

0 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

Aug. 13, 2013

Aug. 07, 2013

Jun. 28, 2013

Feb. 22, 2013

Oct. 31, 2013

Oct. 31, 2012

Oct. 31, 2013

Oct. 17, 2013

Aug. 13, 2013

Aug. 07, 2013

Oct. 31, 2013

Jun. 04, 2013

Jun. 04, 2013

Jun. 04, 2013

Oct. 31, 2013

Feb. 14, 2012

Warrant [Member]

Warrant [Member]

Warrant [Member]

Warrant [Member]

Major Shareholder [Member]

Major Shareholder [Member]

Major Stockholder [Member]

2012 Employee Benefit Plan [Member]

2012 Employee Benefit Plan [Member]

Warrant [Member]

Warrant [Member]

Number of options available to grant under stock plan

'

'

'

'

'

'

'

'

'

'

'

'

'

'

44,500

120,000

Issuance of authorized common stock under stock plan

'

'

'

'

'

'

'

'

'

'

'

'

'

'

16,000

'

Stock issued during period for consideration of services under benefit plan

'

'

'

$20,000

$993

$132,796

$3,212,484

'

'

'

'

'

'

'

$20,000

'

Outstanding stock options expiration term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

expire between February 2014 and January 2016

expire between February 2014 and June 2016

Number of warrants outstanding

'

'

'

'

146,667

'

146,667

'

'

'

'

'

'

'

'

'

Number of warrants surrender or cancelled

'

'

'

'

'

66,667

'

'

'

'

'

'

'

'

'

'

Warrants exercised to purchase common stock

'

'

'

'

'

40,000

'

'

'

'

'

'

'

'

'

'

Common stock issued during period, shares

'

'

13,333

'

'

'

'

'

'

'

'

50,000

'

'

'

'

Common stock issued during period

$30,000

$10,000

$10,000

'

'

'

'

$10,000

'

'

'

$25,000

'

'

'

'

Common stock price per share

$0.50

$0.50

$0.75

'

'

'

'

$1

$1

$1

'

$0.50

$0.50

$1

'

'

Warrant issued to purchase number of common stock, shares

'

'

'

'

'

'

'

10,000

30,000

10,000

'

'

50,000

100,000

'

'

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Schedule of Options Granted Under the Company's Equity Compensation Plans (Details) (USD $)	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012
Accounting Policies [Abstract]	'	'
Number of Options, Outstanding, Beginning balance	5,600	6,000
Number of Options, Granted	'	'
Number of Options, Exercised	'	'
Number of Options, Expired	-1,200	-400
Number of Options, Canceled	'	'
Number of Options, Outstanding, Ending balance	4,400	5,600
Weighted Average Exercise Price, Outsatnding, Beginning balance	$40	$45
Weighted Average Exercise Price, Granted	'	'
Weighted Average Exercise Price, Exercised	'	'
Weighted Average Exercise Price, Expired	$145.83	$80
Weighted Average Exercise Price, Canceled	'	'
Weighted Average Exercise Price, Outstanding, Ending balance	$13.35	$40
Weighted Average Remaining Contractual Term (in years), Outstanding, Beginning	'1 year 2 months 12 days	'2 years 1 month 6 days
Weighted Average Remaining Contractual Term (in years), Outstanding, Ending	'4 months 24 days	'1 year 2 months 12 days
Aggregate Intrinsic Value, Outstanding, Beginning balance	'	'
Aggregate Intrinsic Value, Outstanding, Ending balance	'	'

Weighted_Average_Assumptions_f

Weighted Average Assumptions for Grants (Details)	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012
Stock Options And Warrants	'	'
Risk-free interest rate	0.00%	0.00%
Expected dividend yield	0.00%	0.00%
Expected stock price volatility	0.00%	0.00%
Expected life in years	'0 years	'0 years

Summary_of_Significant_Account4

Summary of Significant Accounting Policies - Schedule of Stock Options Outstanding (Details) (USD $)	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Options outstanding	4,400	5,600	6,000
Weighted Average Remaning Contractual Life	'1 year 2 months 12 days	'2 years 1 month 6 days	'
Weighted Average Exercise Price	$13.35	$40	$45
Options Exercisable	4,400	'	'
Range One [Member]	'	'	'
Range of Exercise Prices	$7.69	'	'
Options outstanding	4,000	'	'
Weighted Average Remaning Contractual Life	'3 months 18 days	'	'
Weighted Average Exercise Price	$7.69	'	'
Options Exercisable	4,000	'	'
Weighted Average Exercise Price, Exercisable	$7.69	'	'
Range Two [Member]	'	'	'
Range of Exercise Prices	$70	'	'
Options outstanding	400	'	'
Weighted Average Remaning Contractual Life	'2 years 2 months 12 days	'	'
Weighted Average Exercise Price	$70	'	'
Options Exercisable	400	'	'
Weighted Average Exercise Price, Exercisable	$70	'	'

Summary_of_Significant_Account5

Summary of Significant Accounting Policies - Schedule of Warrants Granted to Non-employees (Details) (Warrant [Member], USD $)	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012
Warrant [Member]	'	'
Number of Warrants, Outstanding, Beginning balance	146,667	10,000
Number of Warrants, Granted	200,000	413,334
Number of Warrants, Exercised	-40,000	'
Number of Warrants, Canceled	-66,667	-266,667
Number of Warrants, Expired	'	-10,000
Number of Warrants, Outstanding, Ending balance	240,000	146,667
Weighted Average Exercise Price, Outstanding, Beginning balance	$1	$5
Weighted Average Exercise Price, Granted	$0.88	$1
Weighted Average Exercise Price, Exercised	$1	'
Weighted Average Exercise Price, Canceled	$1.50	$1.50
Weighted Average Exercise Price, Expired	'	$5
Weighted Average Exercise Price, Outstanding, Ending balance	$0.90	$1

Weighted_Average_Assumptions_f1

Weighted Average Assumptions for Grants, Warrants (Details)	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012
Risk-free interest rate	0.00%	0.00%
Expected dividend yield	0.00%	0.00%
Expected stock price volatility	0.00%	0.00%
Expected life in years	'0 years	'0 years
Warrant [Member]	'	'
Risk-free interest rate	0.71%	0.72%
Expected dividend yield	'	'
Expected stock price volatility	1.42%	1.89%
Expected life in years	'2 years	'1 year 8 months 12 days

Summary_of_Significant_Account6

Summary of Significant Accounting Policies - Schedule of Warrants Outstanding (Details) (USD $)	12 Months Ended
	Oct. 31, 2013	Oct. 31, 2012	Oct. 31, 2011
Options outstanding	4,400	5,600	6,000
Weighted Average Remaning Contractual Life	'1 year 2 months 12 days	'2 years 1 month 6 days	'
Weighted Average Exercise Price	$13.35	$40	$45
Options Exercisable	4,400	'	'
Range One [Member]	'	'	'
Range of Exercise Prices	$7.69	'	'
Options outstanding	4,000	'	'
Weighted Average Remaning Contractual Life	'3 months 18 days	'	'
Weighted Average Exercise Price	$7.69	'	'
Options Exercisable	4,000	'	'
Weighted Average Exercise Price, Exercisable	$7.69	'	'
Range Two [Member]	'	'	'
Range of Exercise Prices	$70	'	'
Options outstanding	400	'	'
Weighted Average Remaning Contractual Life	'2 years 2 months 12 days	'	'
Weighted Average Exercise Price	$70	'	'
Options Exercisable	400	'	'
Weighted Average Exercise Price, Exercisable	$70	'	'
Warrant [Member]	'	'	'
Options outstanding	240,000	'	'
Options Exercisable	240,000	'	'
Warrant [Member] | Range One [Member]	'	'	'
Range of Exercise Prices	$0.50	'	'
Options outstanding	50,000	'	'
Weighted Average Remaning Contractual Life	'2 years 7 months 6 days	'	'
Weighted Average Exercise Price	$0.50	'	'
Options Exercisable	50,000	'	'
Weighted Average Exercise Price, Exercisable	$0.50	'	'
Warrant [Member] | Range Two [Member]	'	'	'
Range of Exercise Prices	$1	'	'
Options outstanding	190,000	'	'
Weighted Average Remaning Contractual Life	'1 year 9 months 18 days	'	'
Weighted Average Exercise Price	$1	'	'
Options Exercisable	190,000	'	'
Weighted Average Exercise Price, Exercisable	$1	'	'

Commitments_and_Contingencies_1

Commitments and Contingencies (Details Narrative) (USD $)	1 Months Ended		0 Months Ended		1 Months Ended
	Jan. 31, 2006	Aug. 01, 2008	Jan. 31, 2013	Apr. 01, 2012	Oct. 31, 2012
	acre		Jeffrey Nunez [Member]	Jeffrey Nunez [Member]	Jeffrey Nunez [Member]
Area of land for lease	4,100	'	'	'	'
Payment for rent	$3,650	'	'	'	'
Increased monthly lease rent payables	'	3,895	'	'	'
Compensation	'	'	60,000	8,000	'
Increased in monthly compensation	'	'	'	'	12,000
Received bonus in cash	'	'	'	'	20,000
Received bonus in stock	'	'	'	'	40,000
Receivced common stock, value	'	'	'	'	$78,300
Percentage of transaction fee received	'	'	'	'	5.00%

Commitments_and_Contingencies_2

Commitments and Contingencies - Schedule of Future Minimum Facilities Lease Payments (Details) (USD $)	Oct. 31, 2012
Commitments and Contingencies Disclosure [Abstract]	'
2014	$19,475
2015	'

Employee_Retirement_Plan_Detai

Employee Retirement Plan (Details Narrative)	12 Months Ended
	Oct. 31, 2013
Compensation and Retirement Disclosure [Abstract]	'
Percentage of employer contribution	3.00%

Subsequent_Events_Unaudited_De

Subsequent Events (Unaudited) (Details Narrative) (USD $)

0 Months Ended

12 Months Ended

0 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

0 Months Ended

Aug. 13, 2013

Aug. 07, 2013

Jul. 18, 2013

Jun. 28, 2013

Oct. 31, 2013

Oct. 31, 2012

16-May-12

Feb. 21, 2012

Nov. 10, 2010

Oct. 17, 2013

Aug. 13, 2013

Aug. 07, 2013

Jun. 04, 2013

Jan. 29, 2014

Nov. 12, 2013

Jan. 27, 2014

Jan. 09, 2014

Nov. 19, 2013

Dec. 19, 2013

Dec. 13, 2013

Dec. 19, 2013

Dec. 13, 2013

Nov. 13, 2013

Nov. 19, 2013

Nov. 19, 2013

Jan. 29, 2014

Warrant [Member]

Warrant [Member]

Warrant [Member]

Major Stockholder [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Subsequent Event [Member]

Warrant [Member]

Asher Enterprises [Member]

Asher Enterprises [Member]

2014 Employee Benefit Plan [Member]

Major Stockholder [Member]

Major Stockholder [Member]

Major Stockholder [Member]

Major Stockholder [Member]

Chief Scientist [Member]

Jeffrey Nunez [Member]

Employees [Member]

Gregg Newhuis [Member]

Warrant [Member]

Warrant [Member]

2014 Employee Benefit Plan [Member]

Litigation settlement amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$9,894

'

'

'

'

'

'

'

'

'

'

'

Common stock issued during period, shares

'

'

'

13,333

'

'

'

'

'

'

'

'

'

'

'

'

'

'

20,000

20,000

'

'

100,000

'

175,000

'

Common stock issued during period

30,000

10,000

'

10,000

'

'

'

'

'

10,000

'

'

'

'

'

'

'

'

10,000

20,000

'

'

50,000

'

'

'

Common stock price per share

$0.50

$0.50

'

$0.75

'

'

'

'

'

$1

$1

$1

$1

'

'

'

'

'

$0.50

$0.50

$1

$1

$0.50

'

$1

'

Warrant issued to purchase number of common stock, shares

'

'

'

'

'

'

'

'

'

10,000

30,000

10,000

100,000

'

'

'

'

'

'

'

10,000

20,000

'

'

'

'

Number of options available to grant under stock plan

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

525,000

'

'

'

'

'

'

'

'

Issuance of authorized common stock under stock plan

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000

'

'

'

'

'

125,000

'

'

Common stock, price per share

'

'

'

'

$0.01

$0.01

'

'

'

'

'

'

'

'

'

'

'

$0.50

'

'

'

'

'

$1

'

'

Due to Board of Directors for loans payable on demand

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

34,000

Debt instrument interest rate

'

'

'

'

'

'

'

8.00%

10.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.00%

Convertible promissory note

'

'

'

'

149,868

77,368

'

'

'

'

'

'

'

'

'

'

32,500

'

'

'

'

'

'

'

'

'

Legal fees

'

'

5,000

'

'

'

'

'

'

'

'

'

'

2,500

'

'

'

'

'

'

'

'

'

'

'

'

Number of stock issued for conversion of debt, shares

'

'

'

'

'

315,500

'

'

'

'

'

'

'

'

'

68,306

'

'

'

'

'

'

'

'

'

'

Number of stock issued for conversion of debt

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$15,000

'

'

'

'

'

'

'

'

'

'

Debt conversion exercise price

'

'

'

'

'

'

$0.00

'

'

'

'

'

'

'

'

$0.22

'

'

'

'

'

'

'

'

'

'